Introduction {#s1}
============

A key aspect of brain development is the production of the numerous cell types in the correct proportions so they can assemble into nascent networks. Each cell type is generated during a particular time period and from a defined pool of proliferating stem cells ([@bib21]). The number of cells produced is then scaled down based on survival factors produced by target neurons (neurotrophic theory; [@bib11]; [@bib23]; [@bib33]; [@bib48]). The cerebellum represents a powerful system in which to study the phenomenon of cell number scaling during development, since by birth the specification of neuronal lineages is complete but neurogenesis of several cell types has just begun. During the third trimester and first few months of human life the cerebellum undergoes a rapid expansion from a smooth ovoid anlage into a morphologically complex folded structure ([@bib1]; [@bib39]). The folds (lobules) are considered the cerebellar cortex, and they overlay the cerebellar nuclei (CN), two bilaterally symmetrical groups of mediolaterally-arrayed nuclei in mice (medial, intermediate and lateral nuclei), that house the main output neurons of the cerebellum ([@bib47]). The layered cortex has an outer molecular layer, which contains interneurons and the axons of granule cells and dendrites of Purkinje cells (PCs) and lies above a single layer of PC somata intermixed with the cell bodies of Bergmann glia. Below this layer is a dense layer of granule cells called the inner granule cell layer (IGL). PC axonal projections establish the only electrophysiological and physically direct connection between the cerebellar cortex and the CN. The excitatory CN neurons (eCN) are the first neurons to be born in the embryonic cerebellum, followed by their presynaptic partners, the PCs and local CN interneurons ([@bib25]; [@bib50]). Postnatal cerebellar growth in the mouse is principally driven by the expansion of two progenitor populations that produce the presynaptic partners of PCs, granule cells and interneurons, as well as astrocytes ([@bib21]). Genes regulating differentiation of most cerebellar cell types have been identified, but the mechanisms responsible for coordinating the scaling of their cell numbers is poorly understood, despite the known importance for cell type proportions in cerebellar circuit function.

During mouse cerebellar development, neurogenesis occurs in several germinal compartments: 1) the *Atoh1*-expressing rhombic lip which produces the eCN between embryonic day (E) 9.5-E12.5 and then unipolar brush cells directly ([@bib25]; [@bib43]; [@bib55]); 2) the ventricular zone which generates inhibitory PCs by E13.5 and early born interneurons including those that populate the CN ([@bib21]; [@bib22]; [@bib50]); 3) a rhombic lip-derived pool of granule cell precursors (GCPs) that forms an external granule cell layer (EGL) surrounding the cerebellum from E15.5 to postnatal day (P) 15 with an outer layer of proliferating cells and inner layer of postmitotic granule cells ([@bib25]); and 4) a ventricular zone-derived intermediate progenitor pool that expresses nestin, expands after birth and produces astrocytes, including specialized Bergmann glia, and late born interneurons of the molecular layer ([@bib6]; [@bib14]; [@bib35]). The embryonic PCs form a multi-layer beneath the nascent EGL and project to the CN by E15.5 ([@bib46]). Once born, granule cells descend along Bergmann glial fibers to form the IGL, and synapse onto PC dendrites in the overlying molecular layer ([@bib18]; [@bib47]). PCs secrete sonic hedgehog (SHH) after E17.5, which drives the massive postnatal neurogenic phase by stimulating proliferation of GCPs and nestin-expressing progenitors ([@bib10]; [@bib9]; [@bib13]; [@bib14]; [@bib24]; [@bib35]; [@bib57]). PCs thus act in a dual role as a synaptic bridge between the two main rhombic lip-derived glutamatergic neuronal subtypes and as a developmental regulator of postnatal cortex growth driven by proliferation. Scaling of the proportions of postnatally born cells in the cerebellar cortex has been proposed to be regulated by the number of PCs and the amount of SHH they produce ([@bib15]; [@bib14]). However, how the number of eCN neurons and PCs are proportioned during embryogenesis has not been addressed. Furthermore, it is not known whether PCs in the cerebellar cortex are dependent on eCN neurons for their development or scaling.

Engrailed 1 and 2 (*En1/2*) genes encoding homeobox transcription factors provide a powerful genetic entry point for studying developmental scaling of neuron types, since *En1/2* conditional or null mutants have a seemingly well-preserved cytoarchitecture despite suffering cerebellar hypoplasia that preferentially affects particular lobules ([@bib7]; [@bib29]; [@bib34]; [@bib44]). For example, specific loss of *En1/2* in the *Atoh1*-expressing rhombic lip-lineage (*Atoh1-Cre; En1^lox/lox^; En2^lox/lox^* conditional knockouts, referred to as *Atoh1-En1/2* CKOs) results in preferential loss of cerebellum volume in the medial cerebellum (vermis and paravermis), with anterior/central region foliation defects ([Figure 1A](#fig1){ref-type="fig"}; [@bib34]). As a basis for studying the roles of the *En1/2* genes in scaling of cerebellar neurons, we confirmed that the numbers of GCs, PCs, and molecular layer interneurons in the mutants are scaled down in numbers relative to the decrease in cerebellar area, while largely preserving their densities. *Atoh1-En1/2* CKOs nevertheless have motor behavior deficits. The first defect in *Atoh1-En1/2* CKOs was discovered to be death of a subset of eCN neurons after E14.5 in the medial and intermediate nuclei. The early loss of eCN is accompanied by a cell non-autonomous loss of PCs in *Atoh1-En1/2* CKOs. Deletion of *En1/2* in the cerebellum only in GCPs or eCN (*GCP-En1/2* or *eCN-En1/2* CKOs) revealed that *En1/2* play only a minor role in promoting differentiation of GCPs but a major role in viability of a subset of medial and intermediate eCN and secondarily in differential survival of PCs and corresponding cortex growth in the anterior and central regions of the vermis and paravermis. Circuit mapping further revealed that the PCs in the anterior or central regions of the vermis project to different regions of the medial CN (anterior and posterior, respectively). The region-specific scaling of the cerebellar cortex thus could depend on the degree to which particular eCN subpopulations are reduced in the *Atoh1-En1/2* CKOs. Demonstrating that PC numbers are reduced in number when eCN are reduced, we showed that when \~ 40% of embryonic eCN are genetically killed using attenuated diphtheria toxin (DTA) in all three nuclei, PC numbers and cortex growth are correspondingly reduced throughout the cerebellum. We propose a model whereby the number of eCN neurons is involved in setting the growth potential of the cerebellar cortex through supporting survival of a balanced population of PCs that then stimulate proliferation of granule cell and interneuron progenitors.

![Loss of *En1/2* in the rhombic lip-lineage results in reduced growth of the anterior and central vermis and paravermis with scaling of neuron numbers.\
(**A-F**) H and E staining of sagittal sections from the midline (vermis), paravermis and hemispheres of P30 mutant and control cerebella showing reduction of the anterior and central sectors (ASec and CSec) and not the posterior sector (PSec) specifically in the vermis and paravermis. (**G**) Quantification of the total cerebellum area in the vermis, paravermis and hemisphere (n = 4 animals/condition, Two-way ANOVA, F~(1,6)~=43.14, p\<0.0006). (**H**) Quantification of sector areas in the vermis of P30 control and *Atoh1-En1/2* CKO animals (n = 4 animals/condition, Two-way ANOVA, F~(1,9)~=398.277, p\<0.0001). (**I--J**) IGL (**I**) and molecular layer (**J**) sector area quantifications in the vermis as the percent of total average area showing no change in *Atoh1-En1/2* CKOs compared to controls (n = 4 animals/condition). **K**) Immunofluorescence analysis of P30 cerebellar sections for the PC marker Calbindin1 (CALB1) and the pan-neuronal marker NeuN in a *Atoh-En1/2* CKO (**G**) compared to a control. (**L--M**) Quantification of average PC numbers in each sector per midline sagittal section (**L**) showing reductions only in the ASec and CSec, whereas the density of PCs (**M**) is conserved (n = 3 for controls and n = 4 for *Atoh1-En1/2* CKO, J: Two-way ANOVA, F~(1,15)~=72.52, p\<0.0001). (**N**) Quantification of granule cell density in each vermal sector of mutants and controls (n = 4 for each genotype). **O**) Quantification of the density of ParV+ cells in the ML per sector of mutants compared to controls (n = 4 for each genotype, Two-way ANOVA, F~(1,9)~=28.4, p\<0.0005). (**P**) Schematic representation of a half brain with a 3D reconstruction of the eCN in a normal cerebellum. (**Q**) Quantification of eCN neurons in the medial (MN), intermediate (IN) and lateral nuclei (LN) of the CN in one half of *Atoh1-En1/2* CKO cerebella compared to littermate controls (n = 3 per genotype) (Two-way ANOVA, F~(1,12)~=32.29, p=0.0001). Significant *post hoc* comparisons are shown in the figure. CKO: conditional knockout, IGL: internal granule layer, ML: molecular layer, PCL: Purkinje cell layer, PC: Purkinje cell, GC: granule cell. Scale bars B: 500 μm, F-I: 100 μm. Lobule numbers are designated in [Figure 1A](#fig1){ref-type="fig"}.\
Figure 1---source data 1.Summary of the statistics.](elife-50617-fig1){#fig1}

Results {#s2}
=======

Loss of *En1/2* in the rhombic lip-lineage results in reduced growth of the anterior and central vermis and paravermis with scaling of neuron numbers {#s2-1}
-----------------------------------------------------------------------------------------------------------------------------------------------------

Our previous study using 3D Magnetic Resonance Imaging showed a preferential reduction (25%) in the volume of the medial cerebellum (vermis and paravermis) of *Atoh1-En1/2* CKOs ([@bib34]). Although the cytoarchitecture of *Atoh1-En1/2* CKOs appeared preserved, whether scaling of neuron numbers was intact in the mutants was not tested. We therefore determined whether the proportions of different neuron types was preserved in areas of the cerebellum with reduced size. As a proxy for analyzing cerebellum size, we quantified the area of mid-sagittal, paravermis and hemisphere sections of \~P30 animals, and found a 31.2 ± 2.0% and 28.8 ± 4.1% reduction in the vermis and paravermis, respectively but no reduction in the hemispheres of *Atoh1-En1/2* CKOs compared to littermate controls (*En1^lox/lox^; En2^lox/lox^* mice) ([Figure 1A--G](#fig1){ref-type="fig"}). When the vermis and paravermis were divided into three regions - an anterior sector (ASec), anterior to the primary fissure (lobules 1--5); a central sector (CSec), between the primary and secondary fissures (lobules 6--8); and a posterior sector (PSec), posterior to the secondary fissure (lobules 9--10), the PSec had no significant reduction, whereas the ASec and CSec were significantly decreased in area in *Atoh1-En1/2* CKOs compared to littermate controls (ASec and CSec of the midline: 37.1 ± 3.6% and 55.4 ± 2.7%; paravermis: 25.0 ± 1.4% and 46.7 ± 7.0%) ([Figure 1H](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). Thus, *Atoh1-En1/2* CKOs have a specific and differential reduction in the area of the anterior and central regions of the vermis and paravermis.

We next determined whether the areas of the cell layers in the sectors of the vermis and paravermis (normalized to the total areas of each sector) were scaled proportionally in *Atoh1-En1/2* CKOs. As predicted, in *Atoh1-En1/2* CKOs the areas of the IGL and molecular layer were reduced only in the ASec and CSec of the vermis and paravermis and their proportions were well conserved compared to controls ([Figure 1I,J](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1B--E,G,H](#fig1s1){ref-type="fig"}). In order to determine whether the numbers of each cell type in the sectors of the cerebellar cortex were scaled down, we quantified the number and the density of the three major neuron types. The numbers of CALB1+ PCs per midline, paravermis or hemisphere section at \~P30 were indeed found to be reduced specifically in the ASec and CSec of the vermis (31.0 ± 6.0% and 54.1 ± 7.5% reduction, respectively) and paravermis (30.9 ± 7.9% and 37.7 ± 11% reduction, respectively), but their densities remained normal in all sectors of *Atoh1-En1/2* CKOs compared to controls ([Figure 1K--M](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1F,I](#fig1s1){ref-type="fig"}), indicating their numbers had scaled down proportionally. Similarly, quantification of NeuN-expressing granule cells showed that their densities were normal in all three sectors of the vermis ([Figure 1N](#fig1){ref-type="fig"}). Furthermore, the ratio of granule cells to PCs was preserved in the vermis ([Figure 1---figure supplement 1J](#fig1s1){ref-type="fig"}). The ratio of interneurons to PCs or granule cells was preserved in the three sectors of *Atoh1-En1/2* CKOs compared to controls ([Figure 1---figure supplement 1K,L](#fig1s1){ref-type="fig"}), although the density of Parvalbumin+ molecular layer interneurons was mildly increased in the ASec and CSec of mutants (1.2 ± 0.2 and 1.3 ± 0.1 fold, respectively, [Figure 1O](#fig1){ref-type="fig"}). Thus, the major neuron types in the cerebellar cortex are scaled down regionally in numbers and the cell-to-cell ratios of the cortical neurons of the cerebellum are well preserved. Indeed, quantification of the proportion of the EGL that contains the outer layer of proliferating GCPs at P7 showed that the ratio was preserved despite the EGL length being reduced in the ASec and CSec ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}).

*Atoh1-En1/2* mutants have motor deficits {#s2-2}
-----------------------------------------

We next tested whether a smaller cerebellum that has a well scaled cortex can support normal motor behavior, since we had found that irradiated mice with an \~20% reduction in the area of mid-sagittal sections but well scaled layers have no obvious motor defects ([@bib57]). Two motor behavior paradigms and grip strength were tested. Unlike irradiated mice, significant defects in motor behavior were observed in two cohorts of *Atoh1-En1/2* CKOs (1-month-old and 3-month-old). The performance of mutants on trials of the accelerating rotarod over time showed a significant difference, as well as the cumulative measurement of performance in *Atoh1-En1/2* CKOs, with a shorter latency to fall compared to littermate controls at both ages ([Figure 2A--B](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1A--B](#fig2s1){ref-type="fig"}). *Atoh1-En1/2* CKOs did not have a significant decrease in grip strength compared to littermate controls at 3 months ([Figure 2C](#fig2){ref-type="fig"}) although they did at 1 month ([Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}). In a footprint analysis of gait, mutant mice had a significant decrease in stride length at both ages ([Figure 2D--E](#fig2){ref-type="fig"} and [Figure 2---figure supplement 1B-C](#fig2s1){ref-type="fig"}). Thus, *Atoh1-En1/2* CKOs have motor behavior deficits despite the numbers of cells in the cerebellar cortical circuit being well scaled.

![*Atoh1-En1/2* CKO animals show motor behavior defects compared to control animals.\
(**A**) Latency to fall from rotarod at each trial (Two-way ANOVA, F~(1,25)~=14.23, p=0.0009). (**B**) Average latency to fall for 12 week old control animals (n = 17) compared to *Atoh1-En1/2* CKOs (n = 11) (Student's t-test). (**C**) Quantification of grip strength analysis of *Atoh1-En1/2* CKO animals (n = 11) compared to controls (n = 17) (Student's t-test). (**D--E**) Representative images (D) and quantification (E) of footprint analysis performed on control (n = 17) and *Atoh1-En1/2* CKO (or *En1/2* CKO in B) (n = 11) animals (Two-way ANOVA, F~(1,75)~=8.227, p=0.005). Significant *post hoc* comparisons are shown in the figure.](elife-50617-fig2){#fig2}

Loss of *En1/2* in the rhombic lip-lineage results in a preferential loss of medial and intermediate eCN {#s2-3}
--------------------------------------------------------------------------------------------------------

Given the motor deficits, we asked whether the number of rhombic lip-derived eCN are altered in *Atoh1-En1/2* CKOs. Stereology of Nissl-stained large neurons on every other coronal section of half cerebella of *Atoh1-En1/2* CKOs and littermates revealed an \~37.5 ± 4.6% reduction in the total number of large neurons in the *Atoh1-En1/2* CKOs compared to controls. Moreover, the loss of large neurons was specific to the medial and intermediate nuclei ([Figure 1Q](#fig1){ref-type="fig"}, [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"} and [Videos 1](#video1){ref-type="video"}--[2](#video2){ref-type="video"}). Since PCs in the vermis and hemispheres project to the medial and intermediate CN ([@bib21]), there is a correlation between the eCN that are reduced in number in *Atoh1-En1/2* CKOs and the areas of the cerebellum with a growth deficit (paravermis and vermis) in terms of the PC projection maps. We next assessed whether scaling of PCs and eCN was preserved in adult mutants. Since the PCs in lobules 1--8 project primarily to the medial CN whereas most of lobule nine and all of 10 project to the vestibular nucleus ([@bib21]; [@bib54]), we compared the decrease in the number of eCN in the medial nucleus of *Atoh1-En1/2* CKOs to the number of PCs in the ASec and CSec of a half vermis. Interestingly, there was an estimated 1.4 ± 0.1 fold increase in the ratio of the number of PCs to eCN in *Atoh1-En1/2* CKOs compared to controls ([Figure 1---figure supplement 1M](#fig1s1){ref-type="fig"}). Thus, it appears that the PCs numbers did not fully scale down in proportion to the reduction in medial eCN.

###### Stereology 3D reconstruction of a half cerebellum from a control animal at P30.

Green: medial CN, yellow: Intermediate CM, red: Lateral CN.

###### Stereology 3D reconstruction of a half cerebellum from a *Atoh-EN1/2* CKO animal at P30.

Green: medial CN, yellow: Intermediate CM, red: Lateral CN.

ASec and CSec PCs project to distinct regions of the medial CN {#s2-4}
--------------------------------------------------------------

Given that PCs are known to broadly innervate the nuclei closest to them ([@bib21]), one interpretation of our results is that the presynaptic PC partners of the eCN that are depleted in *Atoh1-En1/2* CKOs are the ones that are preferentially lost in mutants, since the hemispheres are spared as well as the posterior lobules of the medial cerebellum. Quantification of the medial CN that remained in *Atoh1-En1/2* mutants compared to controls indicated that there is a preferential loss of the posterior part of the nucleus (see [Videos 1](#video1){ref-type="video"} and [2](#video2){ref-type="video"} and [Figure 1---figure supplement 3](#fig1s3){ref-type="fig"}). Although a comprehensive study of topology based on the anterior-posterior position of PCs in lobules has not been published, it has been shown that neurons of the more posterior region of the medial CN (fastigial oculomotor region) receive functional inputs from PCs in lobules 6 and 7 of the vermis ([@bib19]; [@bib32]; [@bib51]; [@bib59]). We therefore asked whether PCs in the ASec and CSec project to different regions of the medial CN by injecting a Cre-inducible tracer virus (AAV5-EF1a-DIO-mCherry) into lobules 3--5 or lobules 6/7 of \~P30 *Pcp2^Cre/+^* mice ([Figure 3A--B](#fig3){ref-type="fig"}) that express Cre recombinase in PCs ([@bib58]). 1.5 weeks post-injection, brains underwent delipidation to enhance immunofluorescence in the white matter ([@bib40]) and free-floating 50 µm-thick coronal sections were immunostained. Interestingly, we found that labeled PCs in the ASec preferentially innervated the anterior medial CN ([Figure 3C--F](#fig3){ref-type="fig"}), whereas labeled PCs from the CSec, the region with the greatest growth defect, innervated the posterior medial CN ([Figure 3C,G--I](#fig3){ref-type="fig"}). Some labeled PCs in the vermis also targeted the intermediate CN ([Figure 3F and G](#fig3){ref-type="fig"}). These results provide evidence that there could be a causal relationship between the extent to which the eCN are reduced in number in particular locations within each CN and the reduction in the number of their specific presynaptic PCs and associated lobule growth.

![The anterior and central sectors of the vermis preferentially innervate different subregions of the medial CN.\
(**A**) Diagram of scheme used for stereotaxic injection of AAV-DIO-mCherry reporter virus to label PC axons projecting to the CN from the ASec or CSec of *Pcp2^Cre/+^* animals. (**B**) Sagittal section the PC layer of a *Pcp2^Cre^*^/+^ mouse injected with AAV-DIO-mCherry showing successful targeting of PCs. (**C**) Quantification of fluorescence signal density in the anterior medial nucleus (aMN) and posterior medial nucleus (pMN) in animals injected with virus in the ASec or CSec showing that the ASec PCs preferentially innervate the aMN (n = 3, Student's t-test) and CSec labeled PCs preferentially innervate the pMN (n = 3, Student's t-test). (**D--E**) Schematic representations of the anterior (**D**) and posterior (**E**) CN. (**F--I**). Immunofluorescent analysis showing the preferential labeling of the aMN or pMN in mice injected to trace axons projecting from PCs in the ASec (**F--G**) or CSec (**H--I**), respectively. ASec injections and CSec are pseudo-colored in green and red, respectively. Scale bars: 150 μm.](elife-50617-fig3){#fig3}

*En1/2* are transiently expressed in the rhombic lip-lineage during embryonic development {#s2-5}
-----------------------------------------------------------------------------------------

We previously showed that *En1/2* are expressed in subsets of all cerebellar cell types from as early as E8.5 ([@bib12]; [@bib30]; [@bib56]) including in a small percentage of the medial TBR1+ eCN at E17.5 and granule cells primarily after they stop proliferating ([@bib56]). In order to identify which neurons could be responsible for the *Atoh1-En1/2* CKO phenotype, we determined which cells undergo *Atoh1-Cre* recombination and when EN1/2 are expressed in the cells.

First, we confirmed that *Atoh1-Cre* recombines in most eCN by generating mice carrying *Atoh1-Cre* and the *R26^LSL-nTDTom^* reporter allele (*Atoh1-nTDTom* mice) and co-labeled for nuclear TDTom and three eCN markers (NeuN, MEIS2 protein and *Slc17a6* RNA). All but scattered TDTom+ cells expressed NeuN and the vast majority expressed *Slc17a6* (*vGlut2*), and very few cells that expressed either marker did not express TDTom ([Figure 4---figure supplement 1A--R](#fig4s1){ref-type="fig"}). Almost all TDTom+ cells also expressed MEIS2, although at intermediate levels along the medial-lateral axis the co-labeling was less extensive ([Figure 4---figure supplement 1M--O](#fig4s1){ref-type="fig"}). Furthermore, almost all cells expressing *Slc6a5* RNA (marker for glycinergic cells) or *Gad1* (marker for inhibitory neurons) were negative for TDTom ([Figure 4---figure supplement 1S,T](#fig4s1){ref-type="fig"}). As expected, all granule cells in the IGL of the lobules anterior to lobule nine were labeled, with only partial labeling in lobules 9 and 10, and no labeling of PCs or interneurons ([Figure 4---figure supplement 1P](#fig4s1){ref-type="fig"}).

We then examined expression of EN1/2 in the developing rhombic lip-lineage in more detail using an antibody that detects both proteins ([@bib12]) and a new line of mice in which EN2 protein is tagged at the C-terminus with three HA epitopes (*En2^HA/HA^*, see Materials and methods). Using *Atoh1-TDTom* mice, we found that at E12.5, EN1/2 are expressed in the TDTom+ cells of the forming nuclear transitory zone that houses the newly born eCN and the PCs that have migrated away from the ventricular zone ([Figure 4A,B](#fig4){ref-type="fig"}, [Figure 4---figure supplement 2A--C](#fig4s2){ref-type="fig"}). EN1/2 expression levels varied in eCN subpopulations as development progressed. At E15.5, high levels of EN1/2 were observed in TDTom+ cells in the medial and intermediate CN, whereas lateral CN showed reduced expression in TDTom+ cells ([Figure 4C,D](#fig4){ref-type="fig"}). GCPs in the EGL and PCs expressed EN1/2 at high levels at E15.5 ([Figure 4E](#fig4){ref-type="fig"}, [Figure 4---figure supplement 2D--F](#fig4s2){ref-type="fig"}). EN1/2 expression in eCN was confirmed using *En2^HA/HA^* animals ([Figure 4I--P](#fig4){ref-type="fig"}). Immunofluorescent analysis of adjacent sections of E15.5 embryos with MEIS2 and HA antibodies showed expression of EN2 in eCN. Interestingly, only rare eCN expressed EN1 and not EN2 ([Figure 4I--P](#fig4){ref-type="fig"}). By E17.5, the majority of eCN cells had downregulated EN1/2, however scattered populations of TDTom+ cells continued to maintain strong expression, likely in the intermediate nuclei ([Figure 4F--G](#fig4){ref-type="fig"}). At E17.5 EN1/2 were strongly expressed in the inner EGL, where postmitotic GCs reside ([Figure 4H](#fig4){ref-type="fig"}). Finally, in E13.5 *Atoh1-En1/2* CKOs there was not yet a major decrease in EN1/2 protein in the eCN ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}). However, complete loss of EN1/2 protein in the eCN and EGL was observed by E15.5, whereas as expected EN1/2 expression in the PCs did not appear altered ([Figure 4Q--X](#fig4){ref-type="fig"}). Overall, this data shows that EN1/2 are broadly expressed in both rhombic lip- and ventricular zone-derived cells of the cerebellum, however their expression is spatially and temporally dynamic and EN1/2 expression is not lost in the eCN until E15.5 in mutants.

![EN1/2 are dynamically expressed in the rhombic lip-lineage during embryonic development.\
(**A--B**) Immunofluorescent analysis using a pan-EN antibody on sections of E12.5 *Atoh1-Cre/+; R26^LSL-TdTom/+^* embryos showing EN1/2 expression in the TdTomato-expressing (TdT+) cells in the nuclear transitory zone (NTZ) through the mediolateral axis of the developing cerebellum. (**C--D**) Immunofluorescent analysis of E15.5 sections showing EN1/2 expression is mainly in a subset of TdT+ eCN in the medial cerebellum, with scattered expression in lateral TdT+ cells. (**E**) Immunofluorescent analysis of EN1/2 expression in the EGL at E15.5. (**F--G**) Immunofluorescent analysis showing that by E17.5 the majority of the TdT+ cells in the CN no longer express EN1/2 except for a subset of eCN (arrows) in the medial/intermediate eCN. (**H**) Immunofluorescent analysis of the EGL at E17.5 showing higher nuclear expression of EN1/2 in the inner EGL (arrows). (**I--P**) EN1/2 expression was confirmed using an *En2^HA/HA^* mouse line expressing 3xHA-tagged EN2 protein at E15.5 and co-staining sections with pan-EN and anti-HA antibodies. The eCN area was identified using immunofluorescent analysis of adjacent sections for MEIS2. (**Q--X**) Immunofluorescent analysis of sections from E15.5 *Atoh1-En1/2* CKOs and their littermate controls showing loss of EN1/2 expression in the eCN (insets: U,V) and EGL (**W,X**). EN1/2 expression in the PCs is not affected as expected (arrows). MEIS2 and FOXP2 staining of adjacent sections were used to identify eCN and PCs. EGL outlines were determined based on DAPI staining. Scale bars: 100 μm.](elife-50617-fig4){#fig4}

*En1/2* are required in the eCN but not GCPs for growth of the cerebellar cortex {#s2-6}
--------------------------------------------------------------------------------

The cerebellar hypoplasia seen in *Atoh1-En1/2* CKOs could be due to a cell autonomous requirement for *En1/2* in eCN and/or in GCPs. In GCPs *En1/2* could promote their expansion. Alternatively, the reduced number of PCs could be a consequence of the loss of eCN and therefore a decrease in SHH-stimulated proliferation of GCPs and nestin-expressing progenitors that give rise to interneurons ([@bib10]; [@bib13]; [@bib14]; [@bib24]; [@bib57]). As a means to resolve this question, we mutated *En1/2* separately in GCPs or eCN in the cerebellum by taking advantage of the different neurogenic periods for the two cell types in the rhombic lip-lineage ([@bib25]). Using a new *Atoh1-tTA* transgenic line (see Materials and methods) and a *tetO-Cre* line ([@bib37]) we established two doxycycline (Dox) regimens that result in embryonic Cre-mediated recombination in the cerebellum primarily in the eCN or the GCPs/granule cells ([Figure 5A](#fig5){ref-type="fig"}). During administration of Dox, Cre recombination is blocked and then within 3--4 days of Dox withdrawal Cre recombination is restored ([@bib53]; [@bib37]). Given that eCN are generated from *Atoh1*-expressing cells between E9.5-E12.5 ([@bib25]), we found that treatment of animals with Dox from E13.5 until sacrifice resulted in recombination in the cerebellum primarily in the eCN of *Atoh1-tTA/+; tetO-Cre/+; R26^LSL-lacZ/+^* or *Atoh1-tTA/+; tetO-Cre/+; R26^LSL-nTDTom/+^* mice, whereas Dox administration from E8.5 to E12.5 lead primarily to targeting the GCPs and GCs ([Figure 5B](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1A--L](#fig5s1){ref-type="fig"}). With no Dox treatment, both eCN, GCPs and GCs were targeted (lacZ+, [Figure 5B](#fig5){ref-type="fig"} or nTDTom+, [Figure 5---figure supplement 1A--D](#fig5s1){ref-type="fig"}). In addition, consistent with when most precerebellar nuclei are born, many of the nuclei were lacZ+ in *Atoh1-tTA/+; tetO-Cre/+; R26^LSL-lacZ/+^* mice ([Figure 5B](#fig5){ref-type="fig"}). Unexpectedly, the *tetO-Cre* line alone results in nonspecific recombination in neurons in the forebrain and in a small number of PCs in the cerebellum mainly after P7 ([Figure 5---figure supplement 1M--O](#fig5s1){ref-type="fig"}).

![*En1/2* are required in the eCN but not GCPs for growth of the cerebellar cortex.\
(**A**) Schematic explaining genetics used to delete *En1/2* in the eCN and/or GCPs. *Atoh1-tTA; tetO-Cre; En1^lox/lox^; En2^lox/lox^* animals were treated with Dox from either E13.5 until sacrifice to specifically knockout *En1/2* in eCN (*eCN-En1/2* CKO) or between E8.5 and E12.5 to knockout *En1/2* in GCPs (*GCP-En1/2* CKO). No Dox was given to knockout *En1/2* in both cell types in the cerebellum (*eCN+GCP-En1/2* CKO). (**B**) Staining for lacZ activity on sections of *Atoh1-tTA; tetO-Cre; R26^LSL-LacZ/+^* animals at P7 showing the specificity of the Dox regimens. (**C**) Quantification of cerebellum area in the vermis showing reduction only in *eCN+GCP-* and *eCN-En1/2* CKOs compared to their littermate controls at P30 (n = 4 animals/condition, Two-way ANOVA, F~(1,24)~=8.042, p=0.009). (**D,E**) Quantification of cerebellum area based on location showing the area is only reduced in the vermis and paravermis, but not in the hemispheres at P30 in *eCN+GCP-En1/2* CKOs (D, n = 4 animals/condition Two-way ANOVA, F~(1,6)~=12.88, p=0.011) and *eCN-En1/2* CKOs (E, n = 6 animals/condition, Two-way ANOVA, F~(1,10)~=8.34, p=0.016, \*Student's t-test in the paravermis). (**F--S**) Quantifications by sector in the vermis for: overall area (**F,M**), for IGL (**G,N**) or ML (**H, O**) area relative to total sector area, for PC numbers (**I,P**) and for density of PCs (**J,Q**), or ML interneurons (**K,R**) or GCs (**L, S**) in *eCN+GCP-En1/2* CKOs and *eCN-En1/2* CKOs. A reduction in the ASec area is seen in both mutants (*eCN+GCP-En1/2* CKO: Two-way ANOVA, F~(1,18)~=22.07, p=0.0002, *eCN-En1/2* CKOs: Two-way ANOVA, F~(1,36)~=12.4, p=0.0012) and PC numbers in the ASec (*eCN+GCP-En1/2* CKO: Two-way ANOVA, F~(1,18)~=32.51, p\<0.0001, *eCN-En1/2* CKOs: Two-way ANOVA, F~(1,36)~=13.5, p=0.0008), however, cell densities are preserved. Significant *post hoc* comparisons are shown in the figure.](elife-50617-fig5){#fig5}

When the pharmacogenetic strategies were used to ablate *En1/2* in *Atoh1-tTA; tetO-Cre; En1^lox/lox^; En2^lox/lox^* mice, we found that mutation of *En1/2* specifically in GCPs (*GCP-En1/2* CKO) did not lead to a reduction in cerebellar growth compared to littermate controls ([Figure 5C](#fig5){ref-type="fig"}). Significantly, deletion of *En1/2* in embryonic eCN+GCPs (no Dox) or eCN alone resulted in a reduction in the area of the vermis and the paravermis but not the hemispheres compared to littermate controls ([Figure 5D--E](#fig5){ref-type="fig"}), with the significant decrease being in the ASec ([Figure 5F,M](#fig5){ref-type="fig"}, [Figure 5---figure supplement 2A,G](#fig5s2){ref-type="fig"}). The areas of the IGL and molecular layer were reduced in the ASec of the vermis and paravermis and their proportions were conserved relative to the total area of each sector in both *eCN+GCP-En1/2* and *eCN-En1/2* CKOs ([Figure 5G,H,N,O](#fig5){ref-type="fig"} and [Figure 5---figure supplement 2D,E,J,K](#fig5s2){ref-type="fig"}). Similarly, the number of PCs were reduced in the ASec of the vermis and paravermis in both *eCN+GCP-En1/2* and *eCN-En1/2* CKOs, but PC densities were unchanged ([Figure 5I,J,P,Q](#fig5){ref-type="fig"} and [Figure 5---figure supplement 2B,C,H,I](#fig5s2){ref-type="fig"}). We also did not observe any significant changes in the densities of GCs ([Figure 5L,S](#fig5){ref-type="fig"}) and molecular layer interneurons (Pvalb+) ([Figure 5K,R](#fig5){ref-type="fig"}). Finally, the ratio of GCs or INs to PCs was conserved in both mutants ([Figure 5---figure supplement 2F,L](#fig5s2){ref-type="fig"}). Taken together, our data demonstrate that *En1/2* are necessary in the eCN compartment of the rhombic lip-lineage to promote postnatal growth of the cerebellar cortex. The numbers of interneurons and granule cells in the cerebellar cortex are scaled down proportionately to the number of PCs, likely through decreased SHH-stimulated proliferation of progenitors in *eCN-En1/2* CKOs as in *Atoh1-En1/2* CKO ([@bib10]; [@bib13]; [@bib14]; [@bib24]; [@bib57]).

Given the smaller cerebellum in *eCN+GCP-En1/2* and *eCN-En1/2* CKOs we determined the number of eCN using NeuN immunohistochemistry ([Figure 6A](#fig6){ref-type="fig"}, [Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). Quantification of the number of large NeuN+ cells (cell area = 100--600 um^2^) on every other sagittal section of half of the \~P30 cerebellum (see Material and methods, [Figure 6---figure supplement 1C](#fig6s1){ref-type="fig"}) showed a 28.2 ± 2.8% and 30.0 ± 12.7% reduction in the total number of large neurons in the *eCN+GCP-En1/2* CKOs and *eCN-En1/2* CKOs, respectively, and no change in the *GCP-En1/2* CKOs ([Figure 6B](#fig6){ref-type="fig"}). Furthermore, the mediolateral distribution in both *eCN+GCP-En1/2* CKOs ([Figure 6C](#fig6){ref-type="fig"}) and *eCN-En1/2* CKOs ([Figure 6D](#fig6){ref-type="fig"}) showed a significant preferential loss in medial and intermediate CN, similar to the *Atoh1-En1/2* CKOs ([Figure 6E](#fig6){ref-type="fig"} and [Figure 1Q](#fig1){ref-type="fig"}). Also, there was an estimated 1.5 ± 0.43 fold increase in the ratio of the number of vermal PCs in the ASec and CSec to the medial eCN in *eCN-En1/2* CKOs ([Figure 6G](#fig6){ref-type="fig"}), although not significantly in the *eCN+GCP-En1/2* CKOs compared to controls ([Figure 6F](#fig6){ref-type="fig"}).

![eCN numbers are reduced in *eCN+GCP-En1/2* and *eCN-En1/2* CKOs but not in *GCP-En1/2* CKOs at P30.\
(**A**) Representative immunohistochemistry for NeuN in all Dox regimens from midline (left) to lateral (right) cerebellum of P30 control and each of the cell specific *En1/2* CKOs. (**B**) Quantification of NeuN+ cells that are 100--600 um^2^ (eCN size range) showing reduction in *eCN+GCP-* and *eCN-En1/2* CKOs compared to controls, but not in *GCP-En1/2* CKOs (Two-way ANOVA, F~(1,24)~=10.26, p=0.0038). (**C,D**) Mediolateral distribution of 100--600 um^2^ NeuN+ cells in *eCN+GCP-* and *eCN-En1/2* CKO mutants showing a loss in medial and intermediate eCN compared to controls. eCN counts are plotted as bins of 5% percent of the mediolateral distance. (*eCN+GCP-En1/2* CKO: Two-way ANOVA, F~(1,120)~=63.33, p=0.0001; *eCN-En1/2* CKO: Two-way ANOVA, F~(1,240)~=104.4, p=0.0001) (**E**) Quantification of eCN in each nucleus of mutants relative to littermate controls (medial, MN; intermediate, IN; lateral, LN) showing a significant decrease in the MN and IN in *eCN-En1/2* CKO (one-sample t-test per nucleus; MN: p=0.03, IN: p=0.02, LN: p=0.80) and *eCN+GCP-En1/2* CKO mutants (one-sample t-test per nucleus; MN: p\<0.0001, IN: p\<0.001, LN: p=0.437). (**F,G**) Quantification of the ratio of PCs (from anterior and central sectors) to eCN in the medial nucleus in *eCN+GCP-* (**F**) and *eCN-En1/2* CKOs (**G**), compared to the control littermates (Student's t-test). Significant *post hoc* comparisons are shown in the figure. Scale bar = 250 μm. VeN = vestibular nuclei.](elife-50617-fig6){#fig6}

*En1/2* promote differentiation of granule cells {#s2-7}
------------------------------------------------

Interestingly, although in the *GCP-En1/2* CKOs the number of PCs, densities of GCs and molecular layer interneurons and areas of each layer were not altered and the proportion of the area occupied by the molecular layer was conserved, as in *Atoh1-En1/2* CKOs the IGL occupied a slightly smaller proportion of the total area in the CSec and PSec of the vermis ([Figure 5---figure supplement 3A--I](#fig5s3){ref-type="fig"}). This result could mean that fewer GCs are produced in the two mutants. However, this phenotype was very mild and no changes were observed in the GC density or the GC to PC ratio in the *GCP-En1/2* CKOs compared to their control littermates ([Figure 5---figure supplement 3J--K](#fig5s3){ref-type="fig"}). We therefore used our mosaic mutant analysis approach to test whether production of GCs is altered when *En1/2* are removed from scattered GCPs at P2. Indeed, we observed a significant decrease in the proportion of mutant cells (GFP+) in the inner EGL and IGL compared to controls, revealing that deletion of *En1/2* leads to a mild differentiation defect in GCPs ([Figure 5---figure supplement 3L--M](#fig5s3){ref-type="fig"}).

*En1/2* are required for survival of embryonic eCN neurons {#s2-8}
----------------------------------------------------------

The reduction in the number of eCN in adult *Atoh1-En1/2*, *eCN+GCP-En1/2* and *eCN-En1/2* CKOs could be due to a reduced initial production of the neurons or a normal number could be produced and then eCN are specifically lost in the medial and intermediate CN. Loss of PCs in the three mutants could similarly be due to decreased neurogenesis or subsequent loss of the neurons. To distinguish between the possibilities, we determined when a cerebellar growth defect is first detected in *Atoh1-En1/2* CKOs. Our previous analysis showed a clear growth and foliation defect in *Atoh1-En1/2* mutants at P1 ([@bib34]); therefore, we analyzed embryonic stages. Quantification of the cerebellar area of mid-sagittal sections at E17.5 of mutants and controls revealed a small reduction in area in *Atoh1-En1/2* CKOs compared to littermate controls (13.3 ± 5.3%) but not at E15.5 ([Figure 7A,F](#fig7){ref-type="fig"}). In addition, there appeared to be a delay in the formation of the earliest fissures at E17.5 ([Figure 7C,D](#fig7){ref-type="fig"}). We next quantified the number of eCN neurons that expressed MEIS2 in *Atoh1-TDTom-En1/2* CKOs and *Atoh1-TDTom* controls (n = 3 mice of each genotype) at E15.5 and E17.5. All MEIS2+ cells were labeled with cytoplasmic TDTom in *Atoh1-TDTom-En1/2* CKOs ([Figure 7---figure supplement 1A--B](#fig7s1){ref-type="fig"}). In control mice, 67.7 ± 3.8% of the TDTom+ cells expressed MEIS2 at E15.5 and 63.5 ± 3.5% at E17.5, and a similar percentage of TDTom+ cells expressed MEIS2 in mutants ([Figure 7---figure supplement 1A--B](#fig7s1){ref-type="fig"}). None of the TDTom+ cells expressed the PC marker FOXP2, confirming the selective labeling of rhombic lip lineage at embryonic stages ([Figure 7---figure supplement 1C--D](#fig7s1){ref-type="fig"}). The TDTom+ cells in the EGL expressed PAX6, as well as a small number of cells in the forming IGL ([Figure 7---figure supplement 1E--F](#fig7s1){ref-type="fig"}). Quantification of the number of MEIS2+ cells on every other sagittal section of half of the cerebellum revealed no significant change in the total number of MEIS2+ cells at E15.5 in *Atoh1-TDTom-En1/2* CKOs compared to *Atoh1-TDTom* controls ([Figure 7O--P,S](#fig7){ref-type="fig"}). At E17.5, the MEIS2+ cells in the CN of mutants were significantly reduced in number by 18.5 ± 1.6% ([Figure 7Q--R,T](#fig7){ref-type="fig"}). The distributions of the labeled cells along the medial-lateral axis showed a specific reduction in what will likely become the intermediate and medial nuclei ([Figure 7T](#fig7){ref-type="fig"}).

![*En1/2* are required for the survival of the medial eCN and maintenance of PC numbers.\
(**A--F**) Immunofluorescent analysis and quantification of the cerebellar area using DAPI at E15.5 (**A,B**) and E17.5 (C**,D**) showing a significant reduction in area at E17.5 (F; Student's t-test) but not at E15.5 (E; Student's t-test) in *Atoh1-En1/2* CKOs compared to littermate controls (n = 3/condition). A slight delay in foliation was also observed at E17.5 (\* base of folds). (**G--N**) Immunofluorescent analysis of TDTom and TUNEL on sagittal sections from a *Atoh1-TDTom* (**G--H, K--L**) and *Atoh1-TDTom-En1/2* CKO (**I--J, M--N**) embryo showing that apoptosis is increased in the precursors of the medial and intermediate eCN of mutants at E15.5 (**I--J**) and at E17.5 (**G--L**). (**O--R**) Representative images of sagittal sections at the level of the intermediate CN in (**S,T**) stained for MEIS2 and TDTom in *Atoh1-TDTom* (**O,P**) and *Atoh-TDTom-En1/2* CKOs (**Q,R**). (**S,T**) Quantification of the average number of MEIS2+ eCN cells in every second sagittal section along the medial-lateral axis at E15.5 and E17.5 in *Atoh1-TDTom* compared to *Atoh-TDTom-En1/2* CKOs (n = 3 for each genotype) showing reduction in the medial/intermediate eCN at E17.5. eCN counts are plotted as bins of 5% percent of the mediolateral distance (E15.5: Two-way ANOVA F~(1,42)~=2.182, p=0.1471, E17.5: Two-way ANOVA, F~(1,42)~=23.67, p\<0.0001). (**U,V**) Quantification of PCs (FOXP2+ cells, see A-D) showing reduced PC numbers in *Atoh1-En1/2* CKOs compared to controls (n = 3 each genotype) at E17.5 (**V**) but not at E15.5 (**U**) (E15.5: Student's t-test, p=0.88). Scale bars: 100 μm.](elife-50617-fig7){#fig7}

Given the loss of eCN between E15.5 and E17.5 in *Atoh1-En1/2* CKOs, we examined whether cell death was elevated in mutants compared to controls. TUNEL assay for cell death indeed showed an increase in cell death in the region of the TDTom+ eCN population at E15.5 in *Atoh1-TDTom-En1/2* mutants compared to controls and was still observable in some regions at E17.5 ([Figure 7G--N](#fig7){ref-type="fig"}).

*En1/2* loss in eCN triggers a reduction in embryonic Purkinje cell numbers {#s2-9}
---------------------------------------------------------------------------

Given that eCN are lost after E15.5 in *Atoh1-En1/2* CKOs, we determined whether PCs are initially generated in normal numbers and then lost. FOXP2 labeling of PCs revealed no decrease in the number of PCs per midline section at E15.5 in *Atoh1-En1/2* CKO mutants compared to *Atoh1-TDTom* controls ([Figure 7U](#fig7){ref-type="fig"}). At E17.5, however, there was a significant decrease (18.3 ± 1.1%) in the number of PCs per section ([Figure 7V](#fig7){ref-type="fig"}). Unlike *Atoh1-TDTom-En1/2* CKOs, however, no increase in cell death was observed in either *eCN-TDTom-En1/2* CKOs or in *eCN+GCP-TDTom-En1/2* CKOs at E14.5 or E15.5 respectively ([Figure 7---figure supplement 2A,B,K,L](#fig7s2){ref-type="fig"}). At E17.5, however TUNEL+ TdTom+ cells were detected in medial regions of both the *eCN-TDTom-En1/2* CKOs and *eCN+GCP-TDTom-En1/2* CKOs ([Figure 7---figure supplement 2C,M](#fig7s2){ref-type="fig"}). Quantification of MEIS2+ eCN at E17.5, showed a significant reduction in the medial eCN in the *eCN-En1/2* CKOs compared to the littermate controls, but not in *eCN+GCP-En1/2* CKOs ([Figure 7---figure supplement 2D,N](#fig7s2){ref-type="fig"}). However, we observed a large variation in the phenotype of different mutants (both *eCN-En1/2* and *eCN+GCP-En1/2* CKOs) and that mutants which had a reduced number of eCN at E17.5 compared to their littermate controls had increased TUNEL in the medial eCN ([Figure 7---figure supplement 2F--H', P--S'](#fig7s2){ref-type="fig"}). This data shows that there is a delay in cell death in the eCN in the doxycycline-inducible *En1/2* CKOs compared to *Atoh1-En1/2* CKOs ([Figure 7I,J](#fig7){ref-type="fig"}), likely resulting from a delay in induction of *Cre* expression. Corresponding with the delay, we did not observe a reduction in cerebellar area or PC number per midline section in the *eCN-En1/2* or the *eCN+GCP-En1/2* CKOs at E17.5 ([Figure 7---figure supplement 2I,J,T,U](#fig7s2){ref-type="fig"}). In summary, a normal number of eCN and PCs are produced in all the *En1/2* CKOs that affect the eCN and a reduction in PC numbers is observed after eCN die.

Genetic killing of embryonic eCN results in loss of PCs and reduced growth of the cerebellar cortex {#s2-10}
---------------------------------------------------------------------------------------------------

A compelling hypothesis to explain the phenotype of the three *En1/2* CKOs that include the eCN is that when the number of eCN is reduced during embryonic development, the PCs then scale back their numbers, followed by scaling down of the cerebellar cortex growth. We tested this hypothesis by using a pharmacogenetic strategy to kill eCN. Expression of DTA was induced in the eCN using *Atoh1-tTA* and a new line of mice based on our recently described DRAGON allele ([@bib41]) (paper in preparation; [Figure 8A](#fig8){ref-type="fig"}). When *Atoh1-tTA; Atoh1-Cre; Igs7^TRE-LtSL-DTA/+^* mice were administered Dox starting at E13.5 (*eCN-DTA* mice) and analyzed at P30, a significant decrease in the number of eCN was detected (41.2 ± 2.5%) compared to littermate controls (*Igs7^TRE-LtSL-DTA/+^*), and unlike in *Atoh1-En1/2* CKOs, the numbers were decreased across all three nuclei ([Figure 8B,C](#fig8){ref-type="fig"}). Moreover, as predicted since the eCN are killed in all three CN, the area of cerebellar sections and the number of PCs in *eCN-DTA* were reduced not only in the vermis and paravermis, but also in the hemispheres at P30 ([Figure 8D,I](#fig8){ref-type="fig"}). Furthermore, the proportions of IGL and ML area and the ratio of PCs to GCs were preserved, showing that a scaling down of the cerebellar cortex accompanied the loss of eCN ([Figure 8K--M](#fig8){ref-type="fig"}). The estimated ratio of vermal ASec and CSec PCs to medial eCN, however, was increased 1.4 ± 0.3 fold in *eCN-DTA* mice ([Figure 8J](#fig8){ref-type="fig"}). Analysis of TUNEL in *eCN-DTA* mice at E13.5 (through E15.5) showed the expected increased cell death in TDTom+ cells in the nuclear transitory zone and region of the CN ([Figure 8N--Q](#fig8){ref-type="fig"}). Interestingly, PC numbers were normal at E15.5 ([Figure 8R](#fig8){ref-type="fig"}), demonstrating that the reduction in PCs numbers seen at P30 is not a defect in neurogenesis. Thus, similar to *En1/2* CKOs that include the eCN, when eCN are killed soon after they are generated, pre-synaptic partner PCs subsequently are reduced in number and then postnatal growth of the cerebellar cortex is proportionally decreased.

![Genetic killing of embryonic eCN results in subsequent loss of PCs and reduced growth of the cerebellar cortex.\
(**A**) Schematic explaining the genetics used to kill PCs in all three CN. Dox-controlled and recombinase activated gene overexpression (DRAGON) allele was used in combination with the *Atoh1-tTA* and *Atoh1-Cre* to enable embryonic killing of eCN via mis-expression of DTA (Dox given from E13.5 until sacrifice). (**B**) Semi-automated quantification of the large NeuN+ cells in the eCN on every second slide showing significant reduction in eCN-DTA animals at P30 compared to their littermate controls (n = 3 animals/genotype, Student's t-test). (**C**) Cell loss was similar across the mediolateral axis (Two-way ANOVA, F~(1,88)~=52.48, p=0.0001). (**D--G**) H and E analysis (**D,E**) and immunofluorescent analysis (**F,G**) of PCs (CALB1+) and GCs in the IGL (NeuN+) on midsagittal sections showing reduction in cerebellar area but conserved cytoarchitecture. (**H--I**) Quantification of cerebellum area (**H**) and PC numbers (**I**) showing a significant reduction at all mediolateral levels at P30 in *eCN-DTA* animals compared to control littermates (cerebellum area: Two-way ANOVA, F~(1,4)~=19.47, p=0.0116, PC numbers: Two-way ANOVA, F~(1,4)~=38.86, p=0.0034) (V: vermis, PV: paravermis, H: hemispheres). (**J**) Estimated ratio of vermal ASec+CSec PCs to the medial eCN showing it is increased in the *eCN-DTA* animals compared to control littermates (n = 3/genotypes, Student's t-test). (**K--M**) Quantification showing relative ratios of ML (**K**) and IGL (**L**) area compared to total sector area and the ratio of the number of GCs to PC (M, data quantified in the vermis) are unchanged. (**N--Q**) TUNEL staining for cell death showing an increase in the nuclear transitory zone at E13.5 in *eCN-DTA* animals compared to controls (n = 3). (**R**) Quantification of PC numbers (FOXP2+) at E15.5 on midsagittal sections showing that PCs are produced at a normal number in *eCN-DTA* animals (n = 3). Significant *post hoc* comparisons are shown in the figure. DTA: diphtheria toxin fragment A. Scale bars: D-E: 500 μm, F-H and N-Q 100 μm.](elife-50617-fig8){#fig8}

Discussion {#s3}
==========

In summary, the results of our studies show that development of the cerebellum involves a sequence of events that includes the earliest-born neurons, the eCN, having an influence on the final number of their pre-synaptic partner PCs by supporting their survival after PC neurogenesis is complete. Previous research indicates that the PC-derived mitogenic factor, SHH, stimulates the proportional proliferation of GC, interneuron and glial progenitors and thus the level of production of all postnatally derived neurons in the cerebellar cortex ([Figure 9](#fig9){ref-type="fig"}) ([@bib10]; [@bib9]; [@bib13]; [@bib14]; [@bib24]; [@bib35]; [@bib57]). This progression of neurogenesis and cell survival that maintains the overlying circuit constitutes a means by which developmental defects affecting the eCN will lead to adaptations that allow a near normal cytoarchitecture to form in the cerebellar cortex. We hypothesize that once the PCs are born their numbers are then pruned or scaled back to be proportional to the number of eCN and this involves the neurotrophin theory ([@bib23]; [@bib48]) or secretion of a survival factor by eCN.

![Schematic representation of the proposed mechanisms for scaling of neuron numbers in the cerebellum.\
In normal conditions, the first born cerebellar neurons, the eCN, determine the number of their presynaptic partner PCs based on expression of a survival factor. PCs then in turn regulate the number of GCPs and nestin-expressing progenitors (NEPs) that generate the GCs and interneurons, respectively through expression of SHH. In *eCN-En1/2* CKOs involving the eCN, eCN specifically in the medial and intermediate CN die after E15.5 and then their presynaptic partner PCs are lost, resulting in a smaller vermis and paravermis while preserving scaling of neuron numbers in the cortex. In *eCN-DTA* animals, eCN in all nuclei are killed and therefore growth of all regions of the cerebellum is reduced but cortex neurons are scaled. H: hemisphere, PV: paravermis, V: vermis, LN: lateral nucleus, IN: intermediate nucleus, MN: medial nucleus.](elife-50617-fig9){#fig9}

The results of our study show that if the number of PCs is reduced around birth (either in *En1/2* CKOs or due to killing of PCs using DT), then the other neurons generated postnatally in the cerebellar cortex are scaled back in numbers to be proportional to the number of PCs, and thus producing a normally proportioned cytoarchitecture ([Figure 9](#fig9){ref-type="fig"}). Considering the cerebellar cortex as a multilayer structure comprised of unitary tiles containing a single PC which is able to support and specify postnatally-derived cells that contribute to its local circuit, the size of the PC pool can be thought of as a predictor of total postnatal cerebellum growth capacity. As the PCs redistribute into a monolayer across the cerebellar cortex after birth, the smaller population of PCs in *En1/2* CKOs and *eCN-DTA* mice is not able to spread out to form the normal length of the PC layer, since they have the same density at P30 as controls. As SHH expressed by PCs is required for expansion of the two proliferating precursor populations in the postnatal cerebellum (GCPs and nestin-expressing progenitors)([@bib10]; [@bib13]; [@bib14]; [@bib24]; [@bib57]), the scaling back in *En1/2* CKOs and *eCN-DTA* mutants of granule cells and interneurons is likely due to reduced progenitor proliferation because the amount of SHH present in the mutant cerebella is reduced. In this context the cerebellar cortex could be considered as made up of repeated developmental tiles of neurons, and it is interesting to note that our results show that PCs regulate the numbers of their presynaptic neurons that are generated by neurogenesis.

Based on our finding that PCs scale down their numbers soon after eCN die in *En1/2* CKOs and *eCN-DTA* mice, our study has provided evidence that the survival of PCs is dependent on eCN, suggesting a retrograde regulation of cell viability ([@bib11]). The timing of innervation of eCN by PCs fits with this proposal as axons from PCs extend into the CN by E15.5 ([@bib46]). Furthermore, in vitro assays have shown that PC survival is dependent on cell-cell interactions ([@bib2]) or on neurotrophins ([@bib20]; [@bib31]), and mouse mutants have shown that *Bdnf* and *p75^NTR^* null mutants exhibit cerebellar growth and foliation defects with some similarities to *Atoh1-En1/2* mutants ([@bib5]; [@bib4]; [@bib42]). Based on gene expression in the Allen Institute Database and our analysis in *Atoh1-TDTom* mice, *Bdnf* is expressed specifically in the CN at E15.5 ([Figure 9---figure supplement 1](#fig9s1){ref-type="fig"}); thus, it is a good candidate for one of the eCN-derived survival factor for PCs. *Gdnf* is also detected in the CN after birth, suggesting that it could also contribute to long-term survival of PCs in the cerebellum.

It appears that scaling of numbers between the eCN and PCs is not as precise as the scaling within the cerebellar cortex in all the mutants with a decreased number of embryonic eCN (*En1/2* CKOs and *eCN-DTA* mutants). It is possible that the imprecise proportions of eCN and PCs accounts for the motor behavior deficits we observed in *Atoh1-En1/2* CKOs, although the smaller size of the cerebellum (\~30% reduction) could also contribute as it might not be able to support all the long range neural circuits needed for full motor function. In a previous study an \~20% reduction in the cerebellum without disruption of the cytoarchitecture did not lead to obvious motor defects, however the eCN and other cell types were not quantified and the reduction in size was less ([@bib57]). The higher than expected ratio of PCs in the vermis to the medial eCN might reflect the way in which scaling is established. GC and interneuron numbers depend on a precise and deterministic proliferative response to SHH downstream of PC number ([@bib10]; [@bib13]; [@bib14]; [@bib24]; [@bib57]). In contrast, we propose that PC number depends on stochastic retrograde survival factors from the eCN. Moreover, PC survival could be complicated by the convergence ratio of \~40 PCs to each eCN ([@bib38]).

As our model asserts that eCN neurons maintain the survival of their presynaptic PC neurons ([Figure 9](#fig9){ref-type="fig"}), we predict that eCN in the medial and intermediate nuclei that are lost in the greatest numbers in the *Atoh1-En1/2* CKOs are preferentially innervated by PCs in the vermis and paravermis lobules, respectively, that exhibit the most diminution. Consistent with this, in *eCN-DTA* mice where eCN are killed evenly throughout the cerebellum, all regions of the cerebellum are similarly reduced in size. Our finding that the foliation defects in *Atoh1-En1/2* CKOs are distinct from *eCN*- and *eCN*+GCP-*En1/2* CKOs could then be explained by the different *Cre* transgenes used targeting slightly different subsets of eCN or because of the delay in Cre expression using the tTA system. Determination of the projection pattern of PC axons into the CN showed that PCs of the vermis central sector, where lobule growth and PC depletion are most pronounced in *Atoh1-En1/2* CKOs, do indeed preferentially innervate the posterior region of the medial CN that was also preferentially reduced in *Atoh1-En1/2* CKOs. In a complementary fashion, the PCs of the ASec preferentially project to the anterior medial nucleus and part of the intermediate nucleus. Detailed mapping of the eCN that die in each *En1/2* CKO and the innervation patterns of PCs to spatial regions of each CN will be required to fully understand the phenotypes.

The first detected defect in *Atoh1-En1/2* CKOs is death of eCN starting at \~E15.5, indicating that *En1/2* are required in eCN for their survival in the embryo as EN1/2 protein is fully lost in the mutants by E15.5. This survival function of *En1/2* is similar to the proposed function of the genes in other neurons in the brain ([@bib16]; [@bib49]). Conditional knockout of *En1/2* in embryonic postmitotic serotonergic (5-HT) neuron precursors of the dorsal Raphe nucleus (DRN) results in a normal number of 5-HT neurons being initially generated, but the cells then become disorganized through abnormal migration and then a subset of cells undergo significant cell death around birth ([@bib16]). As *En1/2* are ablated in GCPs as well as eCN in *Atoh1-En1/2* mutants, we expected that some of the postnatal growth defect would be due to a requirement for *En1/2* after birth in the GCPs. However, we found that eCN- and not *GCP-En1/2* CKOs have a growth defect and loss of eCN. Mosaic analysis of the role of *En1/2* in GCPs revealed only a mild function in promoting GCP differentiation, consistent with the expression of the EN proteins after birth mainly in the inner EGL where granule cells begin differentiating. This role for *En1/2* is consist with our recent finding that deletion of *En1/2* in GCPs along with over-activation of SHH signaling results in a small increase in the proportion of mutant cells that remain in the proliferative GCP pool ([@bib52]).

In addition to the RL-lineage, *Atoh1-Cre* deletes *En1/2* in the mossy fiber precerebellar nuclei, some of which express *En1/2*. Most of the mossy fiber precerebellar nuclei, but not the inferior olive, are also targeted in *eCN-En1/2* CKOs and *eCN-DTA* mice. Thus, it is possible that some of the phenotypes (behavioral and cellular) seen in both mutant types are a secondary (cell-nonautonomous) effect of loss of *En1/2* or killing with DT of neurons outside the cerebellum. If this is the case, one interpretation consistent with our hypothesis would be that eCN survival is dependent on neurotrophins secreted by precerebellar nuclei neurons. If *En1/2* are required in a subset of mossy fiber neurons for their survival, then their loss in *En1/2* CKOs or *eCN-DTA* mice could result in death of their partner eCN. The scaling back of PCs, however, would not likely be due to loss of mossy fiber neurons since PCs do not project to them.

In conclusion, *En1* and *En2* are required in the eCN after they are produced by the RL for the survival of a subset of medial/intermediate CN neurons, possibly the ones that normally express EN1/2 after E15.5. Loss of a subset of medial/intermediate eCN neurons results in cell non-autonomous loss of the PCs that are their presynaptic partners in the vermis and paravermis ([Figure 9](#fig9){ref-type="fig"}). When eCN are killed in all three nuclei in *eCN-DTA* mutants, PC numbers are reduced in all regions of the cerebellum ([Figure 9](#fig9){ref-type="fig"}). The size of the cerebellar cortex is then scaled back to be proportional to the number of PCs that remain in each region, producing a normal appearing cytoarchitecture. The PCs do not appear to scale back fully to the number of the remaining eCN. Our results have important implications for how scaling of neurons in all brain regions could be regulated by a combination of mitogens that stimulate proliferation of progenitors (neurogenesis) and survival factors that promote the survival of the neurons that are produced (neurotrophic theory) to help match synaptic partner neuron proportions. These proposed mechanisms of scaling could act in local or long distance brain circuits, as well as during evolution of mammals, possibly accounting for the parallel large expansion of the lateral eCN (dentate) and hemispheres in primates.

Materials and methods {#s4}
=====================

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                     Designation                        Source or reference                                 Identifiers                                                      Additional\
  (species) or resource                                                                                                                                                                     information
  --------------------------------- ---------------------------------- --------------------------------------------------- ---------------------------------------------------------------- -------------------------------------------------------
  Genetic reagent (*M. musculus)*   *En1^lox^*                         [@bib45]                                            Jackson Labs stock no: 007918\                                   
                                                                                                                           RRID:[MGI:3789091](https://scicrunch.org/resolver/MGI:3789091)   

  Genetic reagent (*M. musculus)*   *En2^lox^*                         [@bib7]                                             Jackson Labs stock no: 007925\                                   
                                                                                                                           RRID:[MGI:3831084](https://scicrunch.org/resolver/MGI:3831084)   

  Genetic reagent (*M. musculus)*   *Atoh1-Cre*                        [@bib27]                                            Jackson Labs stock no: 011104\                                   
                                                                                                                           RRID:[MGI:3775845](https://scicrunch.org/resolver/MGI:3775845)   

  Genetic reagent (*M. musculus)*   *R26^LSL-TDTom^* (ai14)            [@bib26]                                            Jackson Labs stock no: 007909\                                   
                                                                                                                           RRID:[MGI:3809524](https://scicrunch.org/resolver/MGI:3809524)   

  Genetic reagent (*M. musculus)*   *R26^LSL-nTDTom^* (ai75D)                                                              Jackson Labs stock no. 025106\                                   
                                                                                                                           RRID:[MGI:5603432](https://scicrunch.org/resolver/MGI:5603432)   

  Genetic reagent (*M. musculus)*   *R26^LSL-lacZ^*                                                                        Jackson Labs stock no. 002073\                                   
                                                                                                                           RRID:[MGI:1861932](https://scicrunch.org/resolver/MGI:1861932)   

  Genetic reagent (*M. musculus)*   *Pcp2^Cre^*                        [@bib58]                                                                                                             Made by H. Saito and N. Suzuki, provided by P. Faust.

  Genetic reagent (*M. musculus)*   *TetO-Cre*                         [@bib37]                                            Jackson Labs stock no. 006234\                                   
                                                                                                                           RRID:[MGI:3770672](https://scicrunch.org/resolver/MGI:3770672)   

  Genetic reagent (*M. musculus)*   *Atoh1-tTA*                        described here                                                                                                       See Materials and methods

  Genetic reagent (*M. musculus)*   *En2-HA*                           described here                                                                                                       See Materials and methods

  Genetic reagent (*M. musculus)*   *Igs7^TRE-LtSL-DTA/+^*             To be described elsewhere, modified from [@bib41]                                                                    

  Antibody                          Rabbit anti-MEIS2 (K846)           [@bib28]                                            Gift from Dr. Miguel Torres (CNIC, Spain)                        1:3000 for embryonic tissue, 1:2000 for adult tissue

  Antibody                          Goat anti-FOXP2                    Everest Biotech                                     EB05226\                                                         1:1000
                                                                                                                           RRID:[AB_2107112](https://scicrunch.org/resolver/AB_2107112)     

  Antibody                          Rabbit anti-panEN                  [@bib12]                                                                                                             1:500

  Antibody                          Rabbit anti-Calbindin              Swant Inc                                           CB38\                                                            1:1000
                                                                                                                           RRID:[AB_2721225](https://scicrunch.org/resolver/AB_2721225)     

  Antibody                          Mouse anti-Calbindin               Swant Inc                                           300\                                                             1:500
                                                                                                                           RRID:[AB_10000347](https://scicrunch.org/resolver/AB_10000347)   

  Antibody                          Mouse anti-NeuN                    Millipore                                           MAB377\                                                          1:1000
                                                                                                                           RRID:[AB_2298772](https://scicrunch.org/resolver/AB_2298772)     

  Antibody                          mouse anti-Parvalbumin             Millipore                                           MAB1572\                                                         1:500
                                                                                                                           RRID:[AB_2174013](https://scicrunch.org/resolver/AB_2174013)     

  Antibody                          rat anti-HA                        Sigma                                               11867423001                                                      1:1000

  Recombinant DNA reagent           AAV5-EF1a-DIO-mCherry              UNC Chapel Hill Vector Core                                                                                          

  Commercial assay/Kit              In situ Cell Death Detection Kit   Roche (via Sigma)                                   11684795910                                                      

  Chemical compound/Drug            Doxycycline hyclate                Sigma                                               D9891                                                            0.02 mg/mL in drinking water
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Mouse strains {#s4-1}
-------------

All animal experiments were performed in accordance with the protocols approved and guidelines provided by the Memorial Sloan Kettering Cancer Center's Institutional Animal Care and Use Committee (IACUC). Animals were given access to food and water ad libitum and were housed on a 12 hr light/dark cycle.

All mouse lines were maintained on a Swiss-Webster background: *En1^lox^* ([@bib45]), *En2^lox^* ([@bib7]), *Atoh1-Cre* ([@bib27]), *R26^LSL-TDTom^* (ai14, Jackson labs stock no: 007909) ([@bib26]), *R26^LSL-nTDTom^* (ai75D, Jackson labs stock no: 025106), *R26^LSL-lacZ^* (Stock no. 002073, The Jackson Laboratories), *Pcp2^Cre^* ([@bib58]), *TetO-Cre* (Stock no. 006234, The Jackson Laboratories) ([@bib37]).

*Atoh1-tTA* mouse line was generated by replacing the CreERT2 cassette of the *Atoh1-CreERT2* ([@bib25]) with the coding sequence of tTA2s (including the polyA) from the pTet-Off Advanced vector (Clontech). *En2-HA* mouse line was generated by inserting a six amino acid (GlyLysSerAspSerGlu) linker and three consecutive HA tags ([@bib17]) to the C-terminus of the *En2* gene, replacing the stop codon, via CRISPR-Cas9 using the gRNA 5'- GGCAAGTCGGACAGCGAGTA −3'. One mouse line was confirmed with sequencing to have the correct modification. Homozygous (*En2^HA/HA^*) and *En2^HA/-^* animals did not have any obvious cerebellar phenotype. The *Igs7^TRE-LtSL-DTA/+^* mouse line was generated using our recently described DRAGON allele ([@bib41]) and will be described elsewhere (paper under preparation, [Figure 8A](#fig8){ref-type="fig"}).

Noon of the day that a vaginal plug was discovered was designated developmental stage E0.5. Both sexes were used for all experiments and no randomization was used. Exclusion criteria for data points were sickness or death of animals during the testing period. For behavioral testing, investigators were blinded to genotype during the data collection and analyses.

Doxycycline treatment {#s4-2}
---------------------

Doxycycline (Dox) hyclate (Sigma D9891) was added to the drinking water at a final concentration of 0.02 mg/mL and replaced with fresh Dox every 3--4 days.

Behavioral testing {#s4-3}
------------------

One-month-old (Control: n = 8 and *Atoh1-En1/2* CKOs: n = 9) or 3-month-old (Control: n = 16 and *Atoh1-En1/2* CKOs: n = 11) were used to for all of the motor behavior testing described below.

### Rotarod {#s4-3-1}

Analysis was performed three times a day on three consecutive days. Animals were put on an accelerating rotarod (47650, Ugo Basile), and were allowed to run till the speed reached 5 rpm. Then, the rod was accelerated from 10 to 40 rpm over the course of 300 s. Latency to fall was recorded as the time of falling for each animal. Animals rested for 10 min in their home cage between each trial.

### Grip Strength {#s4-3-2}

A force gauge with a horizontal grip bar (1027SM Grip Strength meter with single sensor, Columbus Instruments) was used to measure grip strength. Animals were allowed to hold the grip bar while being gently pulled away by the base of their tail. Five measurements with 5 min resting intervals were performed for each animal and the data was reported as the average of all trials, normalized to the mouse's weight (Force/gram).

### Footprinting Analysis {#s4-3-3}

After painting the forefeet and hindfeet with red and blue nontoxic acrylic paint (Crayola), respectively, animals were allowed to walk on a strip of paper. Experiments were performed in a 50 cm long and 10 cm wide custom-made Plexiglass tunnel with a dark box at one end. Each mouse was run through the tunnel three times and the distance between the markings were measured and averaged.

Genotyping {#s4-4}
----------

The DNA primers used for genotyping each allele and transgene were as follows: *En1^lox^* ([@bib34]), *En2^lox^* ([@bib34]), *Cre* (*Atoh1-Cre* and *Pcp2^Cre^*): 5'-TAAAGATATCTCACGTACTGACGGTG, 5'-TCTCTGACCAGAGTCATCCTTAGC; *R26^TDTom^* (nuclear and cytoplasmic): 5'-CTGTTCCTGTACGGCATGG, 5'-GGCATTAAAGCAGCGTATCC; *tTA* (*Atoh1-tTA*): 5'-GTCAATTCCAAGGGCATCGGTAAAC, 5'-AATTACGGGTCTACCATCGAGGGC; *tetO-Cre*: 5'-AGCTCGTTTAGTGAACCGTCAG, 5'-CTGTCACTTGGTCGTGGCAGC.

Tissue preparation and histology {#s4-5}
--------------------------------

The brains of all embryonic stages were dissected in cold PBS and immersion fixed in 4% PFA for 24 hr at 4°C. All postnatal stages were transcardially perfused with PBS followed by 4% PFA, and brains were post-fixed in 4% PFA overnight, and washed three times in PBS. Specimens for paraffin embedding were put through an ethanol-xylene-paraffin series, then embedded in paraffin blocks, and sectioned to 10 μm on a microtome (Leica Instruments). Specimens for cryosectioning were placed in 30% sucrose/PBS until they sank, embedded in OCT (Tissue-Tek), frozen in dry ice cooled isopentane, and sectioned at 14 μm on a cryostat unless otherwise stated (Leica, CM3050S).

Immunohistochemistry {#s4-6}
--------------------

Sections of cryosectioned tissues were immersed in PBS for 10 min. After these initial stages of processing, specimens were blocked with blocking buffer (5% Bovine Serum Albumin (BSA, Sigma) in PBS with 0.2% Triton X-100). Primary antibodies in blocking buffer were placed on slides overnight at 4°C, washed in PBS with 0.2% Triton X-100 (PBST) and applied with secondary antibodies (1:1000 Alexa Fluor-conjugated secondary antibodies in blocking buffer) for 1 hr at room temperature. Counterstaining was performed using Hoechst 33258 (Invitrogen). The slides were then washed in PBST, then mounted with a coverslip and Fluorogel mounting medium (Electron Microscopy Sciences).

Hematoxylin and Eosin (H and E) staining was performed for histological analysis and cerebellar area measurements, except at E17.5 where DAPI staining was used. Nissl staining using cresyl violet was used for stereology analysis in the eCN in adult brains.

For eCN counting in *eCN+GCP-En1/2* CKO, *eCN-En1/2* CKO, and *GCP-En1/2* CKO P30 animals, we used nickel enhanced DAB (Ni-DAB) immunohistochemistry for NeuN. All steps were performed at room temperature, unless specified. Cryo-sectioned tissue were washed in PBS for 5 min for three times (hereafter PBS washes). After washes, antigen retrieval was achieved by immersing sections in sodium citrate buffer (10 mM sodium citrate with 0.05% Tween-20, pH 6.0) at 95°C for 40 min. After antigen retrieval, sections were washed in PBS and treated with 50% methanol with 0.03% H~2~O~2~ for 1 hr. Sections were then washed with PBS and applied with anti-NeuN primary antibody solution in blocking buffer (1:1000 dilution in 0.4% PBST with 5% BSA) overnight at 4°C. After washing in PBS the following day, biotinylated anti-mouse secondary antibody (Vector Labs, Burlingame, CA, USA; BA-9200) in blocking buffer (1:500) were applied for 1 hr, followed by PBS washes. Vectastain Elite ABC HRP solution (Vector Labs, Burlingame, CA, USA; PK-6100) in blocking buffer (1:500 for A and B) were applied for 1 hr, followed by PBS washes. Sections were washed in 0.175 M sodium acetate (in dH~2~O) and incubated in Ni-DAB solution (0.02% 3,3'-Diaminobenzidine tetrahydrochloride (Sigma-Aldrich, D5905), 2.5% H~2~O~2~, and 2.5% nickel sulfate in 0.175 M sodium acetate) for 20 min. Ni-DAB reaction was stopped by washing sections in 0.175 sodium acetated followed by PBS washes. After dehydration and defatting (dH~2~O-70% ethanol-95%--95 %-100%-100%-xylene-xylene-xylene, one minute each) slides were mounted with a coverslip and DPX mounting medium (Electron Microscopy Sciences).

Antibodies {#s4-7}
----------

The following antibodies were used at the listed concentrations: Rabbit anti-MEIS2 (1:3000 for embryonic tissue, 1:2000 for adult sections, K846 rabbit polyclonal; [@bib28]), Goat anti-FOXP2 (Everest Cat no: EB05226, 1:1000), Rabbit anti-panEN; 1:200 ([@bib12]), anti-Calbindin (Swant Inc Cat No: CB38, 1:1000 rabbit, Cat No: 300, 1:500 mouse), Mouse α-NeuN (Millipore Cat no: MAB377, 1:1000), mouse α-Parvalbumin (Millipore Cat no: MAB1572, 1:500), rat α-HA (Sigma Cat no: 11867423001).

RNA in situ hybridization {#s4-8}
-------------------------

Probes were in vitro transcribed from PCR-amplified templates prepared from cDNA synthesized from postnatal whole brain or cerebellum lysate. The primers used for PCR amplification were: *Slc17a6*: Forward: 5'-AGACCAAATCTTACGGTGCTACCTC-3', Reverse: 5'-AAGAGTAGCCATCTTTCCTGTTCCACT-3' *Slc6a5*: Forward: 5'- GTATCCCACGAGATGGATTGTT-3', Reverse: 5'- CCATACAGAACACCCTCACTCA-3' *Bdnf*: Forward: 5'-CGACGACATCACTGGCTG-3', Reverse: 5'-CGGCAACAAACCACAACA-3'. Primers were flanked in the 5' with SP6 (antisense) and T7 (sense) promoters. Specimen treatment and hybridization were performed as described previously ([@bib3]).

Image acquisition and analysis {#s4-9}
------------------------------

All images were collected with a DM6000 Leica fluorescent microscope or a Zeiss Axiovert 200 with Apotome or NanoZoomer Digital Pathology (Hamamatsu Photonics) and processed using ImageJ (NIH) or Photoshop (Adobe). Image quantification was performed with ImageJ.

For the cerebellar, sector, IGL, and ML area, H and E stained slides were used. A region of interest was defined by outlining the perimeter of the outer edges of the region quantified. Threesagittal sections/brain at each mediolateral level were analyzed, and values were averaged for each brain.

Cell counts were obtained using the Cell Counter plugin for ImageJ (NIH). The average number of total Calbindin positive PCs per section was determined from three sections per animal in each region (vermis or midline, paravermis and hemispheres). PC density was calculated by dividing the average number of PCs by the average length of the PCL in each region (three sections per animal per region). Granule cell density was measured by counting the NeuN+ cells in a 40x frame of the IGL from three sections/animal and region and dividing the number of cells by the area counted. GC density for different vermis sectors was obtained from lobule 3 (anterior), lobules 6--7 (central), and lobule 9 (posterior) from three vermis sections per animal. GC numbers per section in the vermis were calculated by multiplying the average GC density by the average area of the IGL (n = 3 sections per animal). Interneuron densities were calculated as the average number of Parvalbumin+ cells in the ML of one section for lobule 3 (anterior), 6--7 (central) or 9 (posterior) divided by the average ML area per section (n = 5 sections per animal). The total number of ML Parvalbumin+ interneurons was extrapolated by multiplying the average density of the three lobules times the average total ML area.

Ratios of the the number of GCs to PCs, Parvalbumin+ cells in the ML to PCs and GCs to Paravalbumin+ cells in the ML were calculated using the total numbers calculated above per average vermis sections. The ratio of PCs (vermal ASec+CSec) to eCN (medial) was obtained by dividing the extrapolated number of PCs in the ASec and the CSec of a half vermis (PC average number in the ASec and CSec on one midline section multiplied by half the number of 14 μm-thick sections in a half vermis) divided by the number of medial eCN present on every second section of half a cerebellum using our two different methods (semi-automated eCN counting of cell type specific *En1/2* CKOs and *eCN-DTA* mutants or stereology for *Atoh1-En1/2* cKOs).

Stereology {#s4-10}
----------

Brains were paraffin embedded, as described above, and sectioned coronally at 10 μm. The sections were Nissl stained and every other section was analyzed to prevent double counting neurons split in serial sections. For each analyzed section in sequential order from rostral to caudal, the section perimeter of the CN on one half of the cerebellum was traced and each large projection neuron was registered. Neurons were categorized by nucleus at each coronal level by reference to coronal sections at that level of the cerebellum in an adult mouse brain atlas ([@bib36]). Sections were then aligned into a 3D representation in NeuroLucida.

Semi-automated eCN counting methodology {#s4-11}
---------------------------------------

For eCN counting using NeuN labeled slides, every other section was analyzed using a semi-automated quantification. Slides were scanned with a slide scanner (NanoZoomer Digital Pathology) at 20X, and images containing the eCN from each section was exported at 10X resolution. eCN from each image was cropped using Photoshop and saved as TIFF format. Using a batch 'analyze particle' process in ImageJ, each image was converted to 8-bit, sharpened, despeckled, and outliers (radius = 5, threshold = 30) were removed. Particles sized 100--600 um^2^ from each preprocessed image was quantified ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). The size range was determined by analyzing the area of NEUN and nTDTom double positive cells or NEUN positive/nTDTom negative cells in an *Atoh1-Cre/+; R26^LSL-nTDTom/+^* animal ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}), which marks eCN neurons. To validate the reliability of the automated counts, manual counting of NeuN positive cells and semi-automated counting were compared ([Figure 6---figure supplement 1](#fig6s1){ref-type="fig"}). To determine the medial, intermediate and lateral CN neuron number, we compared the sagittal sections stained with NeuN to an adult mouse brain atlas ([@bib36]). Sagittal sections matching lateral 0.48 mm to 0.72 mm in the atlas were counted as medial CN, lateral 0.84 mm to 1.80 mm as intermediate (includes the dorsolateral medial CN, but not lateral CN), and lateral 1.92 mm to 2.64 mm as lateral CN. On average, the first 20% of the sections from midline were medial CN, 20--70% were intermediate CN and 70% from midline to most lateral section were lateral CN.

Stereotactic injection {#s4-12}
----------------------

One-month-old mice were anesthetized by isoflurane inhalation and head fixed in a stereotactic frame (David Kopf Instruments) with an isoflurane inhaler. The head of the animal was shaved, disinfected with ethanol and betadine, and a midline incision was made from between the eyes to the back of the skull. Coordinate space for the system was calibrated by recording the coordinates of Bregma and Lambda. After a small hole was drilled in the skull over the injection site, the needle was robotically injected into the cerebellum position specified by atlas coordinate (Neurostar StereoDrive). For targeting the ASec and PSec, coordinates of the injection were −6.00 mm from Bregma, −2.2 mm deep from dura, and 8.5 mm from Bregma, 4.2 mm deep from dura, respectively. One μL of 10^12^Tu/mL AAV5 virion in PBS was injected in 20 millisecond pulses at 10 psi with a Picospritzer. The needle was left in situ for 5 min, and then removed by 50 μm increments over about a minute. The scalp was then sealed by Vetbond adhesive, 0.1 μg/g of buprenorphine was administered for postoperative analgesia, and the animal was placed in a heated chamber for recovery. Brains from these animals were analyzed 1.5 weeks after surgery. Brains were processed for cryosectioning as above but were sectioned at 30 μm. To establish the accuracy of the injections to the appropriate sectors, *R26^TDTom/TDTom^* P30 animals were injected stereotactically with either AAV5-pgk-Cre virus or trypan blue dye in the midline of either the ASec (lobules 3--5) or CSec (lobules 6--7). Whole mount imaging of TDTom signal verified that the transduced cells remained restricted to the injection area and spread minimally in the lateral axis beyond the vermis. The tracing was done by injecting AAV5-EF1a-DIO-mCherry virus into *Pcp2^Cre^*^/+^ animals. The AAV-EF1a-DIO-mCherry plasmid was constructed by Karl Deisseroth and virus was packaged as serotype five and prepared to 10^12^ Tu/mL by the UNC Chapel Hill Vector Core.

Tissue delipidation for tracing analysis {#s4-13}
----------------------------------------

After perfusion, postfix, and PBS washes as described above, brains were delipidated with a modified Adipo-Clear procedure ([@bib8]) to enhance immunolabeling in heavily myelinated regions. The brain samples were washed with a methanol gradient (20%, 40%, 60%, 80%) made by diluting methanol with B1n buffer (0.1% Triton X-100/0.3 M glycine in H2O, pH 7.0), 30 min each step; then washed in 100% methanol for 30 min twice, and reverse methanol/B1n gradient (80%, 60%, 40%, 20%) for 30 min each; then in B1n buffer for 30 min twice. After delipidation, samples were washed in PBS and sectioned with a vibratome at 50 μm. The free-floating sections were immunolabeled for mCherry for analysis of PC projections.

Statistical analysis {#s4-14}
--------------------

Prism (GraphPad) was used for all statistical analyses. Statistical comparisons used in this study were Student's two-tailed t-test and Two-way analysis of variance (ANOVA), followed by post hoc analysis with Tukey's test for multiple comparisons. Relevant F-statistics and the significant p-values are stated in the figure legends and the p-values of the relevant *post hoc* multiple comparisons are shown in the figures. Results of the non-significant comparisons and a summary of all of the statistical analyses performed can be found in [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}. The statistical significance cutoff was set at p\<0.05. Population statistics were represented as mean ± standard deviation (SD) of the mean, except for the behavioral data presented in [Figure 2](#fig2){ref-type="fig"}, [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} and the mediolateral eCN number distribution graphs shown in [Figures 6](#fig6){ref-type="fig"} and [8](#fig8){ref-type="fig"}. Population statistics in these figures are represented as mean ± standard error (SE). No statistical methods were used to predetermine the sample size, but our sample sizes are similar to those generally employed in the field. n ≥ 3 mice were used for each experiment and the numbers for animals used for each experiment are stated in the figure legends.

Funding Information
===================

This paper was supported by the following grants:

-   http://dx.doi.org/10.13039/100000025National Institute of Mental Health R37MH085726 to Alexandra L Joyner.

-   http://dx.doi.org/10.13039/100000065National Institute of Neurological Disorders and Stroke R01NS092096 to Alexandra L Joyner.

-   http://dx.doi.org/10.13039/100000054National Cancer Institute P30CA008748-48 to Alexandra L Joyner.

-   http://dx.doi.org/10.13039/100000065National Institute of Neurological Disorders and Stroke F32NS080422 to Ryan T Willett.

-   http://dx.doi.org/10.13039/100012636New York State Stem Cell Science C32599GG to N Sumru Bayin.

-   Kavli Neural Systems Institute at the Rockefeller University to Zhuhao Wu.

We thank past and present members of the Joyner laboratory for discussions and technical help, especially Dr. Sandra Wilson for initiating studies on the cerebellar nuclei in *En1/2* mutants. We are grateful to Dr. Miguel Torres for providing a polyclonal antibody to all isoforms of mouse MEIS2. We thank Drs. H Saito, N Suzuki and P Faust for the *Pcp2^Cre^* mouse line. This work was supported by grants from the NIH to ALJ (NIMH R37MH085726 and NINDS R01NS092096) and RW (NINDS 5F32NS080422), and a National Cancer Institute Cancer Center Support Grant \[P30 CA008748-48\]. NSB was supported by a NYSTEM postdoctoral fellowship (\#C32599GG). ZW was supported by the Kavli Neural Systems Institute at the Rockefeller University.

Additional information {#s5}
======================

No competing interests declared.

Conceptualization, Formal analysis, Funding acquisition, Investigation, Writing---original draft, Writing---review and editing.

Formal analysis, Supervision, Investigation, Writing---review and editing.

Formal analysis, Investigation, Writing---review and editing.

Formal analysis, Investigation, Writing---review and editing.

Formal analysis, Investigation, Writing---review and editing.

Investigation, Methodology.

Investigation, Methodology.

Resources, Methodology.

Investigation, Methodology.

Resources, Methodology.

Resources, Methodology.

Resources, Funding acquisition.

Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Writing---original draft, Project administration, Writing---review and editing.

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) under an approved protocol from MSKCC (Protocol no: 07-01-001).

Additional files {#s6}
================

Data availability {#s7}
=================

No datasets were generated.

10.7554/eLife.50617.sa1

Decision letter

Mason

Carol A

Reviewing Editor

Columbia University

United States

Wingate

Richard JT

Reviewer

King\'s College London

United Kingdom

Friedman

Wilma J

Reviewer

Rutgers University

United States

In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

This study by Willett et al., from the lab of Alexandra Joyner, explains how cerebellum size scales to the cerebellar nuclei (dCN)during their assembly. Using conditional deletion of engrailed genes, expressed in excitatory cerebellar nuclei neurons, the authors investigated how neuron numbers are scaled across the cerebellar circuit. The number of Purkinje cells is matched to that of excitatory cerebellar nuclei (eCN) neurons, through eCN regulation of Purkinje cell survival, and Purkinje cell regulation of granule cell proliferation, via secreted sonic hedgehog. This matching depends on a trophic effect exerted by eCN neurons via Purkinje afferents, with implications for alterations of behavior observed in the mutant animals. Such rules of cell numbers vis a vis targets, and size regulation of gross brain structure, will be of great interest to those studying circuits in other CNS regions.

**Decision letter after peer review:**

\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for submitting your work entitled \"Cerebellar nuclei neurons dictate growth of the cortex through developmental scaling of presynaptic Purkinje cells\" for consideration by *eLife*. Your article has been reviewed by a Senior Editor, a Reviewing Editor, and three reviewers. The reviewers have opted to remain anonymous.

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife*.

The reviewers found your study on how neuron numbers are scaled across the cerebellar circuit of great interest. You propose that the number of PCs is matched to that of eCN neurons, through cerebellar nuclei neuron regulation of Purkinje cell survival, and Purkinje cell regulation of granule cell proliferation. This matching depends on a trophic effect exerted by eCN neurons via PC afferents, with implications for alterations in these circuits on the behavioral changes observed in the mutant animals.

In our online consultation amongst the reviewers, the reviewers called this a \"lovely study\", a well conducted and valuable descriptive characterization of the developmental scaling of cerebellar cells. Your proposed principle of matching cell number of afferents and targets could indeed be applicable to other circuits. Nonetheless, even with this appealing overarching hypothesis and clear data presentation consistent with the hypothesis, the reviewers feel that the interesting ideas you presented were not tested, and the data lack any indication of the causal chain of events that would regulate the relatively stable proportions of cell numbers.

Some aspects the reviewers thought were overinterpreted include:

1\) Target-dependence of Purkinje neuron survival (concerns of granule cell contribution, and extension to more lateral sites).

2\) The matching mechanisms based on target-dependent support does not appear to underpin a physiological depletion of supernumerary PCs (e.g., no evidence for developmental cell death in wt samples), suggesting that PCs might be already matched to eCN at their birth.

3\) The generalization that such selection is \'the\' developmental mechanism that matches numbers of cerebellar nuclei neurons to that of cortical cells.

These aspects are not simply details but constitute the core hypothesis of the paper.

The study as is presents a set of observations on approximate scaling/compensation within a circuit. Addressing the suggested revisions on these descriptive aspects could be done within two months. However, you would then have to play down the very interesting discussions about scaling, and this approach would lessen the interest of the study. Because testing the model experimentally without confounding components would most likely take much longer, we regret that *eLife* cannot proceed with the manuscript at this time. If you feel you can address these issues some time in the future, we would be happy to consider a new version of the manuscript that addresses the reviewers\' concerns.

*Reviewer \#1:*

In this study Willett and collaborators investigate the mechanisms of cerebellar development in *Atoh-En1/2* conditional mutants. They nicely show that defined sectors of the mutant vermis display a reduced area and in those sectors both cortical layers and neuron numbers are overall proportionally scaled. Moreover, the number of granule cells and interneurons is reduced to fit the decreased number of PCs. The authors also find that the number of excitatory neurons in mutant medial and intermediate cerebellar nuclei is reduced due to cell death during embryonic development. This associates with PC death, thus explaining the decreased PC number. On these bases, the authors propose that the number of PCs is matched to that of eCN neurons, which would therefore act as the ultimate organizer of cortical morphogenesis. They also suggest that this matching depends on a trophic effect exerted by eCN neurons on their PC afferents.

The presented experiments are well performed, and the results add new data, important to understand cerebellar development. They further propose a mechanism that has general implications for CNS circuit formation.

To fully strengthen their data and clarify their interpretation, the authors should address these points:

\- According to the proposed model, and based on the reduction of eCN in the intermediate nucleus, one would predict that the number of PCs is also reduced in the lateral vermis and paravermis, where PCs projecting to this nucleus are located. Nonetheless, while alterations in the vermis of mutants are well documented (and detailed here in mid-sagittal sections), the extent of defects related to variations in PC numbers in those other regions remains unclear. Thus, the assessment of PC scaling also at those other sites is relevant to strengthen the results and the ensuing proposed model.

\- The matching mechanisms based on target-dependent support as proposed by the authors does not appear to underpin a physiological depletion of supernumerary PCs (no evidence for developmental cell death in wt samples), suggesting that PCs are already matched to eCN at their birth. This leaves open the possibility that a mitogen-based matching mechanism operates on PC progenitors at earlier developmental stages, similar to postnatal Shh-mediated actions. However, the authors only discuss target-dependence as a scaling mechanism for PC:eCN ratio. Can the authors comment on this?

\- It is intriguing to speculate that a specific increase in eCN number in the lateral nuclei underlies the expansion of human cerebellar hemispheres. Is there any evidence from imaging studies or comparative neuroanatomy to support this hypothesis?

Further remarks:

\- Figure 1K, M Despite the ratio of interneurons to PCs in *Atoh-En1/2* CKOs does not differ from wt mice, the density of ML interneurons increases in the ASec and CSec at the midline. This result is intriguing: is there any hypotrophy of PC?

\- Figure 7. In the pictures (F-I) some labelled PCs appear tagged with distinct colors in seemingly corresponding lobules. However, according to the experimental design, distinct tags should selectively label PCs in different cerebellar areas. Please, clarify this point.

*Reviewer \#2:*

This manuscript by Willett et al., examines the interactions among cell types in the developing cerebellum, and the ways in which the neuron numbers are scaled across a circuit. They describe a change in overall cerebellar architecture, with a decrease in size of the central vermis, in a conditional knock out in which the homeobox genes engrailed1 and 2 (En1 and 2) are eliminated in *Atoh1*-expressing neurons. Based on the regional changes in cerebellar nuclei, Purkinje cells and granule cells, they propose a model in which the cerebellar nuclei neurons regulate survival of the Purkinje cell afferents, and the Purkinje cells regulate proliferation of granule cells. They implicate alterations in these circuits in behavioral changes observed in the mutant animals. Overall the studies are well executed and documented, and the potential implications are interesting.

1\) A major concern is that there is not strong evidence for the inference that Purkinje cell number is largely dictated by selective survival while cerebellar granule cell number is largely dictated by regulated proliferation. All cell numbers are \"set\" by regulated proliferation and survival. Clearly there are mutations in which granule cell numbers are altered due to impaired survival rather than altered proliferation. Thus, the data here, while interesting, do not really address a novel question or scaling mechanism.

2\) The anatomic basis for the behavioral deficits observed is not well established. Other non-cerebellar cells such as cells within the spinal cord or those in the vestibular system also express *Atoh1*. Are these other areas affected in the CKO and could they contribute to the behavioral changes observed?

3 The ratio of PCs to eCN neurons is 1.4 to 1. This might suggest that other regulators are important, rather than the idea that eCNs are the major determinant of PC cell number, but that the survival promoting mechanism is imprecise.

*Reviewer \#3:*

The authors look at changes to the development of the cerebellum when Engrailed (En) 1 and 2 are conditionally knocked out in the *Atoh1* lineage. The mutation leads to a non-uniform shrinkage of the cerebellum. However, the relative proportions principal cerebellar neurons within affected regions of the (medial) cortex remain constant. The densities of granule cells and Purkinje cells are the same. The density of molecular layer interneurons increases (1.2-1.3 fold). There is a 63% loss in number of excitatory neurons (eCN) in the medial and intermediate cerebellar nuclei. The ratio of Purkinje cells to eCN is marginally increased (1.4 fold). Mutants mice show a motor and grip deficit.

A previous report (using transgenic reporters) described En1 and En2 expression in the *Atoh1* lineage (Wilson et al., 2011): It showed that the medial EGL expresses En1 (exclusively) and En2 (predominantly). En1 is expressed in CN (highest laterally) and En2 only in the most medial CN. Here the authors show only relatively weak (Figure 4E) or restricted (Figure 4L,M) En1/2 protein expression in the CN. Nevertheless, there is a very clear targeted cell death in only medial CN from e15.5 (Figure 5) coupled with a lower number of FoxP2-positive cells (Purkinje cell linear: Figure 6). The cell density in the Purkinje layer itself, however, is constant (Figure 2G). Cell death in in the FoxP2 population was not examined, however, axon labelling (Figure 7) suggests that Purkinje cells in the vermis will have predominantly have targeted dying neurons of the medial eCN.

The paper beautifully illustrates the proportional scaling of cell number that characterises cerebellar growth and points towards cell communication as a core feature of this process. The fact that En1/2 expression in Purkinje cells is normal in this model means that changes in cell number at e17.5 must be downstream of changes in the *Atoh1* lineage. The authors propose (from an early stage in the paper) that this is specifically retrograde to eCN loss.

Overall, this paper presents an attractive hypothesis that owes much to classical studies of retrograde regulation of cell death (Cowan, Fawcett, OLeary, 1984), particularly in the visual system, and the neurotrophic hypothesis (Levi-Montalcini and Hamburger), which both need some form of acknowledgement. It is interesting in the context of the massive expansion of the dentate (lateral) nucleus in primates in parallel to the cerebellar hemispheres, and also interesting to consider in the context of a lack of cerebellar nuclei in teleost fish.

To me, there seem to be two main questions.

\- Is this the right experiment to test this hypothesis?

\- If not an optimal study, do the result unambiguously support the conclusion that is so forcefully expressed in the abstract and introduction?

1\) Is this the right experiment?

The optimal approach would be to selectively delete a subset of eCN using genes or combination in a transectional approach to limit mutation to the cerebellum. All effects would then be downstream of the loss of eCN. The authors experimental paradigm goes some way towards this. However, there are confounding factors. They acknowledge that pre-cerebellar En1/2 populations may be affected and a cause of hypoplasia. However, the main cause for concern should be the prominent expression of En1 and to a lesser extent En2 in the medial EGL (Wilson et al., 2011) at e17.5. Could Purkinje cell layer assembly be affected by events in the EGL? There is no synaptic link at this stage, however there is reciprocal signalling both from Purkinje to EGL (via Shh) and EGL to Purkinje cells (via reelin).

2\) Do the results support the conclusions?

This is a beautifully documented analysis of scaling within the cerebellum and the changes in cell number, density and overall size are unambiguous. The authors are very keen to assert that there is a cascade of change that stems from eCN death at e15.5. There are a couple of key points that weaken this case.

a\) Does eCN cell death occur because of the cell-autonomous loss of En1 and En2? Unclear. The characterisation of expression of En1/2 within the affected CN is quite poor. Unless I have misunderstood, there is only a very small population in the intermediate nucleus that are double labelled for TFTom and EN1/2 (Figure 4L-N). This needs to be better explained.

b\) Could a smaller Purkinje cell layer result in an anterograde loss of eCN? Yes. This certainly is the case in the Lurcher mouse (Heckroth, 1994), although the timing of Purkinje cell loss is later that in the model described here.

In both cases the answers are not a strong enough to warrant the forcefulness of the conclusions -- the model remains a hypothesis in my view. This means that while the paper shows a beautiful example of scaling and an unexpected motor deficit due to a smaller medial cerebellum, there is no clear discrimination of the causal chain of events that regulates the relatively stable proportions of cell numbers.

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for resubmitting your work entitled \"Cerebellar nuclei excitatory neurons regulate developmental scaling of presynaptic Purkinje cell number and organ growth\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Marianne Bronner (Senior Editor), a Reviewing Editor, and three reviewers. The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

The reviewers, two previous and one new, favor the novel conclusion of your studies that he cerebellum size scales to the early assembled cerebellar nuclei. The results are valid and suitable for publication in *eLife*, and you have appropriately addressed the points raised by the previous reviewers.

However, although none of the criticisms of your resubmission require additional experiments/analyses, all point to issues that should be better discussed and amended. From the reviews, see below, and the reviewer consultation, we agree that the Discussion section is lacking relative to the Results section that include your new data added to the original submission last year.

The reviewers noted a lack of clarity in the conclusions and especially in the Discussion section. There are five areas that need improvement:

1\) The new DTA data has almost entirely superseded the use of En conditional mice in support of the main conclusions of the study. The Discussion section should to be overhauled to clearly contrast the outcomes of these two experiments.

As the Discussion section is currently structured, the En-conditional mice seem to introduce confusion:a) They generate a pattern of regional PC loss that is difficult to explain: \"Detailed mapping of the eCN that die in each En1/2 CKO and the innervation patterns of PCs to spatial regions of each CN will be required to fully understand the phenotypes\".b) They generate behavioral deficits that also have an unclear origin, currently attributed to \"the imprecise proportions of eCN and PCs\" or a smaller cerebellum being unable to \"support all the long range neural circuits needed for full motor function\".

2\) The information and statements in the rebuttal letter and the spirit of the changes in the text do not quite match up.

For example, on behavior, the relatively clear rebuttal statement that \"some of the behavior deficits could therefore be due to defects in cell types that are not the focus of the paper\" is not represented in the Discussion (some anatomical \"phenotypes\" could be \"secondary (cell-nonautonomous) effect of loss of En1/2 or killing with DT of neurons outside the cerebellum\".

3\) The comment of reviewer 2 on additional mechanisms possibly participating in the scaling (e.g. precursor proliferation) already emerged in the former round of revision and was recognized in your rebuttal. We suggest that you tone down statements presenting the observed scaling back as \'the\" mechanism that determines the cell number of their pre-synaptic partner PCs.

4). Clarity is need on the possible mechanistic explanation for the regional variability you see, namely, the mechanisms of cell death. As reviewer 2 notes, \"\'Growth\' can reflect many different processes. Is this only due to apoptosis of neurons generated? Is there an effect on progenitor proliferation?\" In addition, explanation is needed on regional differences in cerebellar growth and in the Methods, how the ratio of PC to eCN in the medial nucleus is calculated.

5\) The reviewers also call for more contextual information about the potential role of neurotrophins, especially citation of classical literature on neurotrophins.

*Reviewer \#1:*

The manuscript has been extensively revised since its last submission with the addition of new data. These have addressed comments arising from the previous submission and the work provides convincing support for the hypothesis that the cerebellum size scales to the early assembled cerebellar nuclei.

*Reviewer \#2:*

In this manuscript, Willet et al., investigate the effect of deleting Engrailed1/2 specifically from the eCN neuronal population in the cerebellum, demonstrating that when eCN neurons are lost due to the deletion of EN1/2, there is a concomitant decrease in neuron number across the entire circuit, with reduced numbers of Purkinje cells and granule cells. When they delete En1/2 from the cerebellar nuclei, there is a reduction of neurons in the medial and intermediate, but not lateral, nuclei. The authors beautifully demonstrate that there is a corresponding loss of the Purkinje cell presynaptic partners, and discuss the scaling of neuron numbers to maintain proportionality in the circuitry.

There are many interesting and novel aspects to this study. Using developmental regulation of the timing of the *Atoh1-Cre* to remove EN1/2 specifically from the CNs or the GPCs highlights the different EN functions in different neuronal populations. Tracing the projections of specific PC populations to their respective CN regions to show that the PCs that project to the medial and intermediate eCN are the ones that are lost. The use of DTA to kill eCN confirmed that the rest of the cerebellar populations scale down when eCN neurons are decreased, although this decrease occurred in the cerebellar hemispheres as well as the vermis and paravermis.

However, there are a number of questions associated with this study that are not addressed, and could at least be raised in the Discussion section.

1\) They mention (subsection "*En1/2* are required in the eCN but not GCPs for growth of the cerebellar cortex") that En1/2 are necessary in the eCN compartment to promote cerebellar growth, but \"growth\" can reflect many different processes. Is this only due to apoptosis of neurons generated? Is there an effect on progenitor proliferation?

2\) They demonstrate that PCs are generated in normal numbers and there is increased cell death, suggesting that they lack trophic support from their target eCN neurons, although the PCs did not scale down completely. However, why there are fewer eCN neurons in the *eCN-En1/2* cKO is not addressed, what is the mechanism by which the loss of En1/2 leads to the death of these eCN neurons?

3\) There is no explanation or hypothesis provided in the Discussion for the regional differences in cerebellar growth in the *Atoh1-En1/2* CKO, that the decreased size is only seen in the vermis and paravermis and not in the hemispheres, and only in the anterior and central, but not posterior sector. Is En1/2 equally expressed in all these regions? Does the *Atoh1-Cre* remove En1/2 from those regions that don\'t show decreased size after they have already developed?

4\) There was no scaling of the PV-positive inhibitory interneurons (Figure 5), possible reasons for that could be discussed.

*Reviewer \#3:*

The authors have addressed all concerns previously expressed. With a new set of elegant genetic experiments, they have now significantly strengthened the evidence for:

\- a developmental dependency of PCs on eCNs for they survival -- this applies to vermis, paravermis and hemispheres;

\- normal neurogenesis for eCNs and PCs in the examined mutants, and scaling of PC numbers after the beginning of eCN death;

\- lack of impact of subtle alterations in granule cell development on the observed PC loss and major cerebellar cortical growth defects.

Thus, taken together, the current data nicely support the view that PC numbers are matched to their postsynaptic partners and show that the cerebellar cortex is then organized proportionally to the PC numbers.

To this reviewer, however, the author\'s statement at the beginning of the discussion somehow appears to go beyond these conclusions: \'.. whereby the earliest-born neurons, the eCN, determine the cell number of their pre-synaptic partner PCs\'. According to what the authors write in the rebuttal \'our paper is addressing a.. scaling mechanism, which might be most prevalent after injury or used normally for making minor adjustments\'. Here the authors appear to recognize that additional mechanisms should be in place to match eCN and PCs, likely acting during neurogenesis. Therefore, the above reported statement sounds too strong and should be tuned down to better fit the results of this study.

This reviewer is also confused now about how the ratio of PC to eCN in the medial nucleus is calculated. When reading the methods, it seems that the average number of PCs at the vermis midline (e.g. about 350+190 in WT mice, Figure 1L) is divided by the number of neurons in the medial nucleus (about 1000 in corresponding WT mice, Figure 1Q). The result here cannot be 20 as plotted in Figure 1---figure supplement 1M. Have I missed some information? Please, clarify.

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for resubmitting your work entitled \"Cerebellar nuclei excitatory neurons regulate developmental scaling of presynaptic Purkinje cell number and organ growth\" for further consideration by *eLife*. Your revised article has been evaluated by Marianne Bronner (Senior Editor) and a Reviewing Editor.

We are pleased to inform you that the reviewers were satisfied with your revisions, most of which made your arguments better organized and the text clearer. Reviewer 1, however, had a few additional suggestions for further clarifying your writing, as follows:

Introduction: \"In turn, the PC-derived mitogenic factor, SHH, stimulates the proportional proliferation of GC, interneuron and glial progenitors and thus the level of production of all postnatally derived neurons in the cerebellar cortex (Figure 9)\"

The suggested change is: rather than \"in turn\", it would be better to say \"Previous research indicates that\". This avoids any implication that these insights on Shh arise from this study. In addition, in many places, you cite the influence of Shh without making reference to the previous studies and so this also needs to be amended. Also, Shh is sometimes expressed as SHH -- make consistent.

Discussion section: \"...as it might not be able to support all the long range neural circuits needed for full motor function.\"

This hypothesis needs a little elaboration. Is there any evidence from other studies that a small cerebellum, per se, results in motor deficits (i.e., in Shh mutants)?

Discussion section: \"One idea for the higher ratios of vermal PCs in lobules 1-8 to eCN in the medial CN in the mutants is that the difference reflects the mechanism by which scaling is attained. In the case of eCN:PC scaling, we propose the process depends on the availability of a survival factor (such as a neurotrophin), since the PCs die after E15.5 when all the neurons have been born, whereas the PC:GC or PC:interneuron scaling depends on the amount of mitogen produced (SHH) which stimulates proliferation of two progenitor pools. One additional possibility related to eCN:PC scaling is that since each PC projects to many eCN (Person and Raman, 2011), if the survival of PCs is dependent on a factor secreted by eCN, then it might be that a greater proportion of PCs can survive than in normal homeostasis because the remaining PCs project to more of the remaining eCN in mutants than normal and thus receive sufficient survival factor.\"

These two sentences are rather tortuous and difficult to extract the argument. Please consider clarifying. Reviewer 1 tried to re-write the paragraph in a way that was clearer, in this way:

\"The higher than expected ratio of PCs in the vermis might reflect the way in which scaling is established. GCs and interneuron numbers depend on a precise and deterministic proliferative response downstream of PC number. However, PC number depends on potentially stochastic retrograde survival factor from the eCN. Moreover, PC survival may be complicated by the presence of collateral axon projections from some PC (Person and Raman, 2011) to eCN less affected by the mutation.\"

10.7554/eLife.50617.sa2

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

> \[...\] Some aspects the reviewers thought were overinterpreted include:
>
> 1\) Target-dependence of Purkinje neuron survival (concerns of granule cell contribution, and extension to more lateral sites).
>
> 2\) The matching mechanisms based on target-dependent support does not appear to underpin a physiological depletion of supernumerary PCs (e.g., no evidence for developmental cell death in wt samples), suggesting that PCs might be already matched to eCN at their birth.
>
> 3\) The generalization that such selection is \'the\' developmental mechanism that matches numbers of cerebellar nuclei neurons to that of cortical cells.
>
> These aspects are not simply details but constitute the core hypothesis of the paper.
>
> The study as is presents a set of observations on approximate scaling/compensation within a circuit. Addressing the suggested revisions on these descriptive aspects could be done within two months. However, you would then have to play down the very interesting discussions about scaling, and this approach would lessen the interest of the study. Because testing the model experimentally without confounding components would most likely take much longer, we regret that eLife cannot proceed with the manuscript at this time. If you feel you can address these issues some time in the future, we would be happy to consider a new version of the manuscript that addresses the reviewers\' concerns.

We thank the reviewers for their constructive comments. We agree that additional evidence for a specific role of excitatory cerebellar nuclei neurons (eCN) in scaling the number of Purkinje cell (PCs) would strengthen our hypothesis. We have therefore performed an extensive series of additional genetic experiments that we think should satisfy the reviewer's concerns and provide direct evidence for our proposed cell number scaling mechanism. We have used a transgenic mouse we made that expresses tTA from *Atoh1* regulatory sequences in the rhombic lip lineage in conjunction with a *tetO-Cre* line and our *En1/2* conditional alleles in order to delete *En1/2* only in embryonic eCN or GCPs, by feeding the mice doxycycline before or after the eCN are generated (E13.5). We find that indeed when *En1/2* are removed from GCPs, there is no decrease in the growth of the cerebellar cortex, but when *En1/2* are removed from the eCN or eCN+GCPs there is a significant decrease in eCN and PC numbers and the cerebellum is smaller than normal. As a second approach to test that PC numbers scale to eCN numbers, we used the same *Atoh1-tTA* in combination with *Atoh1-Cre* in an intersectional approach with a new transgene we made to transiently express attenuated diphtheria toxin (DTA) in eCN at embryonic day \~9-13 (*eCN-DTA*). We indeed found that killing \~40% of eCN results in a reduction in the number of PCs, and reduced growth of the cerebellar cortex. As further evidence that PCs scale to their eCN postsynaptic partners, the eCN that die in *En1/2* CKOs and *eCN-DTA* animals are different, with only the medial and intermediate eCN being reduced in *En1/2* CKOs whereas there is uniform eCN death across the medio-lateral axis in *eCN-DTA* mice. As a consequence, cerebellar size is only reduced in the vermis and paravermis in the *En1/2* CKOs, whereas in *eCN-DTA* the hemispheres were also smaller. Finally, we also used our mosaic mutant analysis approach to identify any minor role of *En1/2* in GCPs by deleting the genes in scattered GCPs at P2 and analyzing the output of GCs at P8. We found there is a minor but significant decrease in the proportion of GCs generated of all the mutant cell (GCPs+GCs) and a complementary increase in the proportion of mutant GCPs, revealing that *En1/2* normally play a minor role in promoting GC differentiation. When all GCPs are mutant for *En1/2* using our GCP-specific approach, there is no measurable long term defect in overall cerebellar growth and the density of the GCs in the internal granule cell layer (IGL) is maintained, but the area of the IGL relative to the cerebellum is slightly reduced. We have expanded our Discussion section and hypothesis to include all our new results.

> Reviewer \#1:
>
> \[...\] To fully strengthen their data and clarify their interpretation, the authors should address these points:
>
> \- According to the proposed model, and based on the reduction of eCN in the intermediate nucleus, one would predict that the number of PCs is also reduced in the lateral vermis and paravermis, where PCs projecting to this nucleus are located. Nonetheless, while alterations in the vermis of mutants are well documented (and detailed here in mid-sagittal sections), the extent of defects related to variations in PC numbers in those other regions remains unclear. Thus, the assessment of PC scaling also at those other sites is relevant to strengthen the results and the ensuing proposed model.

As suggested by the reviewer, we have quantified the area and PC numbers in the paravermis and hemispheres of *Atoh1-En1/2* CKO mutants as well as our new models and find a significant decrease in the area and number of PCs in the paravermis but not the hemispheres in all *En1/2* CKOs involving the eCN, and also in the hemispheres in *eCN-DTA* mutants. Since our new embryonic eCN killing model (*eCN-DTA*) and not the *En1/2* CKOs leads to uniform eCN loss across the medio-lateral access, the specific reduction in the area of the hemispheres in the *eCN-DTA* mice provides additional evidence that PC numbers (and growth of the cerebellar) cortex is influenced by the number of their postsynaptic eCN partners.

> \- The matching mechanisms based on target-dependent support as proposed by the authors does not appear to underpin a physiological depletion of supernumerary PCs (no evidence for developmental cell death in wt samples), suggesting that PCs are already matched to eCN at their birth. This leaves open the possibility that a mitogen-based matching mechanism operates on PC progenitors at earlier developmental stages, similar to postnatal Shh-mediated actions. However, the authors only discuss target-dependence as a scaling mechanism for PC:eCN ratio. Can the authors comment on this?

The reviewer brings up an interesting alternative that we had considered and may well operate during neurogenesis. However, our paper is addressing a later, or second scaling mechanism, which might be most prevalent after injury or used normally for making minor adjustments. As shown in our original manuscript, we found that the number of eCN and PCs are not significantly reduced at E15 in *Atoh1-En1/2* CKOs, and then both are reduced at E17.5. In our new *eCN-En1/2* CKOs, eCN numbers are only partially reduced at E17.5 and PC numbers are normal at E17.5 but both are significantly reduced at P30. Similarly, in our *eCN-DTA* model where eCN are killed before E15.5, PC numbers are not reduced at E15.5 but are reduced at P1 (not shown) and in the adult cerebellum. Thus, PC numbers are not scaled back after the eCN die. Since the number of PCs is initially normal and becomes reduced after the eCN are reduced, we propose a target derived factor for this aspect of number scaling we are studying.

> \- It is intriguing to speculate that a specific increase in eCN number in the lateral nuclei underlies the expansion of human cerebellar hemispheres. Is there any evidence from imaging studies or comparative neuroanatomy to support this hypothesis?

We agree with the reviewer's hypothesis and have added the idea to the Discussion section. From our reading of the scant literature on quantification of eCN in humans, there are indeed more in the lateral nuclei, as they are much larger than in mouse and divided into several subgroups, further supporting the idea that the number of eCN dictates the growth of the local cerebellar circuitry.

> \- Figure 1K, M Despite the ratio of interneurons to PCs in Atho-En1/2 CKOs does not differ from wt mice, the density of ML interneurons increases in the ASec and CSec at the midline. This result is intriguing: is there any hypotrophy of PC?

We have quantified PC size in the *Atoh1-En1/2* CKO mutants and there is no hypertrophy in PCs, see [Author response image 1](#respfig1){ref-type="fig"}. We have therefore not added the results to the paper.

![Quantification of PC soma size in *Atoh1-En1/2* CKOs.\
No overall signficiant difference between mutant and control PCs (One-way ANOVA, p\>0.1).](elife-50617-resp-fig1){#respfig1}

> \- Figure 7. In the pictures (F-I) some labelled PCs appear tagged with distinct colors in seemingly corresponding lobules. However, according to the experimental design, distinct tags should selectively label PCs in different cerebellar areas. Please, clarify this point.

We apologize for the confusion. The colors were pseudo-colored, as only one viral construct was used and were not meant to correspond to former 7D,E (now Figure 3D,E). We have clarified this in the figure legend.

> Reviewer \#2:
>
> \[...\] 1) A major concern is that there is not strong evidence for the inference that Purkinje cell number is largely dictated by selective survival while cerebellar granule cell number is largely dictated by regulated proliferation. All cell numbers are \"set\" by regulated proliferation and survival. Clearly there are mutations in which granule cell numbers are altered due to impaired survival rather than altered proliferation. Thus, the data here, while interesting, do not really address a novel question or scaling mechanism.

As described above, we would like to note that the PCs and eCN are born in normal numbers in *Atoh1-En1/2* CKOs, and then they are both scaled back. This is a phenotype not previously described, and we think that with the extensive new genetic studies (see above) our work provides novel insights into a second type of scaling.

> 2\) The anatomic basis for the behavioral deficits observed is not well established. Other non-cerebellar cells such as cells within the spinal cord or those in the vestibular system also express Atoh1. Are these other areas affected in the CKO and could they contribute to the behavioral changes observed?

The reviewer brings up a good point that we had previously mentioned in the Discussion section. We have previously shown that *En1/2* are not expressed in spinal cord *Atoh1*-derived cells (Sillitoe, 2010). *En1/2* do have a dynamic and complicated expression pattern in some precerebellar nuclei derived from the *Atoh1*-lineage. Some of the behavior deficits could therefore be due to defects in cell types that are not the focus of the paper. Unfortunately, all the available Cre lines that are specific to the eCN are also expressed in the precerebellar nuclei, including our new tTA/Cre approach. We nevertheless think the behavior results are worthwhile including in the paper, but we are open to removing them given all the additional experimental results that have been added.

> 3 The ratio of PCs to eCN neurons is 1.4 to 1. This might suggest that other regulators are important, rather than the idea that eCNs are the major determinant of PC cell number, but that the survival promoting mechanism is imprecise.

We agree with the reviewer that since it appears that PCs do not fully scale back to the reduced number of eCN, now seen in additional models, the scaling mechanism cannot be as simple as we previously stated. We have elaborated on this idea in the Discussion section.

> Reviewer \#3:
>
> \[...\] To me, there seem to be two main questions.
>
> \- Is this the right experiment to test this hypothesis?
>
> \- If not an optimal study, do the result unambiguously support the conclusion that is so forcefully expressed in the abstract and introduction?
>
> 1\) Is this the right experiment?
>
> The optimal approach would be to selectively delete a subset of eCN using genes or combination in a transectional approach to limit mutation to the cerebellum. All effects would then be downstream of the loss of eCN. The authors experimental paradigm goes some way towards this. However, there are confounding factors. They acknowledge that pre-cerebellar En1/2 populations may be affected and a cause of hypoplasia. However, the main cause for concern should be the prominent expression of En1 and to a lesser extent En2 in the medial EGL (Wilson et al., 2011) at e17.5. Could Purkinje cell layer assembly be affected by events in the EGL? There is no synaptic link at this stage, however there is reciprocal signalling both from Purkinje to EGL (via Shh) and EGL to Purkinje cells (via reelin).

We agree with the reviewer that the paper would be strengthened by having CKOs that remove *En1/2* only in the eCN or GCPs in the embryonic cerebellum. As described above, we have now performed multiple complicated genetic experiments to dissect the roles of *En1/2* in eCN and GCPs during cerebellar development. As described above, we made a transgenic mouse that expresses tTA from *Atoh1* regulatory sequences in the rhombic lip lineage and combined it with a *tetO-Cre* line and our *En1/2* conditional alleles and fed the mice doxycycline after or before the eCN are generated (E13.5) in order to delete *En1/2* only in the eCN or GCPs in the embryonic cerebellum. We find that indeed when *En1/2* are removed from GCPs, there is no decrease in the growth of the cerebellar cortex, but when *En1/2* are removed from the eCN there is a significant decrease in eCN and PC numbers and the cerebellum is smaller than normal. There are subtle differences in the regional hypoplasia using the two strategies, which likely reflects either the subgroup of eCN that Cre is expressed in using *Atoh1-Cre* or *Atoh1-tTA* or more likely that the timing of Cre since Cre will be slightly delayed using tTA. We also used our mosaic mutant analysis approach to identify any minor role of *En1/2* in GCPs by deleting the genes in scattered GCPs at P2 and analyzing the output of GCs at P8. We found there is a minor but significant decrease in the proportion of GCs generated of all the mutant cell (GCPs+GCs) and a complementary increase in the proportion of mutant GCPs, revealing that *En1/2* normally promote GC differentiation. When all GCPs (and not eCN) are mutant for *En1/2* using *Atoh1-tTA*, there is no long term defect in cerebellar growth or the density of the GCs in the internal granule cell layer (IGL), but the area of the IGL as a proportion of cerebellar area is slightly reduced. We have expanded our Discussion section to include all our new results.

> 2\) Do the results support the conclusions?
>
> This is a beautifully documented analysis of scaling within the cerebellum and the changes in cell number, density and overall size are unambiguous. The authors are very keen to assert that there is a cascade of change that stems from eCN death at e15.5. There are a couple of key points that weaken this case.
>
> a\) Does eCN cell death occur because of the cell-autonomous loss of En1 and En2? Unclear. The characterisation of expression of En1/2 within the affected CN is quite poor. Unless I have misunderstood, there is only a very small population in the intermediate nucleus that are double labelled for TFTom and EN1/2 (Figure 4L-N). This needs to be better explained.

We have expanded our analysis of EN1/2 expression in the embryonic eCN, including using a new *En2* HAtagged allele we generated. *En1/2* expression is dynamic and most broadly in the eCN before E15.5, and then remains in a subset of eCN. There is growing evidence from published results and our current study that EN1/2 play a transient role in promoting differentiation and survival of several neuron types. In the cells that maintain *En1/2* expression, we speculate that the genes play an additional role in neuron function. As we have now deleted *En1/2* only in the eCN and still find cell death in the TdTom+ eCN, we have shown that EN1/2 are important for cell survival.

> b\) Could a smaller Purkinje cell layer result in an anterograde loss of eCN? Yes. This certainly is the case in the Lurcher mouse (Heckroth, 1994), although the timing of Purkinje cell loss is later that in the model described here.

We think this is unlikely in our mutants, since in the published papers death of CN neurons in Lurcher mutants occurs months after the loss of PCs. Since earlier killing leads to rapid replacement of PCs, we cannot kill the PCs at an earlier stage.

> In both cases the answers are not a strong enough to warrant the forcefulness of the conclusions -- the model remains a hypothesis in my view. This means that while the paper shows a beautiful example of scaling and an unexpected motor deficit due to a smaller medial cerebellum, there is no clear discrimination of the causal chain of events that regulates the relatively stable proportions of cell numbers.

We think that our new experimental studies, including specific DTA-mediated embryonic killing of 40% of the eCN throughout the medial-lateral axis, add substantially to our paper and provide strong support for our hypothesis.

\[Editors\' note: the author responses to the re-review follow.\]

> The reviewers, two previous and one new, favor the novel conclusion of your studies that he cerebellum size scales to the early assembled cerebellar nuclei. The results are valid and suitable for publication in eLife, and you have appropriately addressed the points raised by the previous reviewers.
>
> However, although none of the criticisms of your resubmission require additional experiments/analyses, all point to issues that should be better discussed and amended. From the reviews, see below, and the reviewer consultation, we agree that the Discussion section is lacking relative to the Results section that include your new data added to the original submission last year.
>
> The reviewers noted a lack of clarity in the conclusions and especially in the Discussion section. There are five areas that need improvement:
>
> 1\) The new DTA data has almost entirely superseded the use of En conditional mice in support of the main conclusions of the study. The Discussion section should to be overhauled to clearly contrast the outcomes of these two experiments.

We had previously done this where it seems appropriate in the Discussion section but have now added additional reference to both types of mutants.

> As the Discussion section is currently structured, the En-conditional mice seem to introduce confusion:a) They generate a pattern of regional PC loss that is difficult to explain: \"Detailed mapping of the eCN that die in each En1/2 CKO and the innervation patterns of PCs to spatial regions of each CN will be required to fully understand the phenotypes\".b) They generate behavioral deficits that also have an unclear origin, currently attributed to \"the imprecise proportions of eCN and PCs\" or a smaller cerebellum being unable to \"support all the long range neural circuits needed for full motor function\".

We have addressed all the specific comments of the reviewers below and tried to clarify the conclusion or hypotheses we made in the Discussion section. (a) Data presented in Figure 3 shows that the central region where the lobule size and PC loss is the greatest in *Atoh1-En1/2* CKOs project to the area of the medial eCN (posterior) where the greatest eCN loss is observed (Figure 1Q and Figure 1---figure supplement 3). (b) Interpretation of the behavioral phenotypes is discussed further below in the specific comments of the reviewers including that it could involve hindbrain defects.

> 2\) The information and statements in the rebuttal letter and the spirit of the changes in the text do not quite match up.
>
> For example, on behavior, the relatively clear rebuttal statement that \"some of the behavior deficits could therefore be due to defects in cell types that are not the focus of the paper\" is not represented in the Discussion (some anatomical \"phenotypes\" could be \"secondary (cell-nonautonomous) effect of loss of En1/2 or killing with DT of neurons outside the cerebellum\".

We have clarified that by 'phenotype' we mean both cellular defects and behavior deficits.

> 3\) The comment of reviewer 2 on additional mechanisms possibly participating in the scaling (e.g. precursor proliferation) already emerged in the former round of revision and was recognized in your rebuttal. We suggest that you tone down statements presenting the observed scaling back as \'the\" mechanism that determines the cell number of their pre-synaptic partner PCs.

We did not mean to imply that this is the only mechanism, certainly proliferation of VZ progenitors and nestinexpressing progenitors after birth are critical step. We have tried to clarify and tone down our conclusions throughout the paper.

> 4). Clarity is need on the possible mechanistic explanation for the regional variability you see, namely, the mechanisms of cell death. As reviewer 2 notes, \"\'Growth\' can reflect many different processes. Is this only due to apoptosis of neurons generated? Is there an effect on progenitor proliferation?\" In addition, explanation is needed on regional differences in cerebellar growth and in the Methods, how the ratio of PC to eCN in the medial nucleus is calculated.

We addressed the specific comments of reviewer 2 on growth and regional differences below and modified our conclusions accordingly.

How the PC to eCN ratio was calculated was previously described in the Materials and ethods section of our resubmission. We have expanded the material and methods section to add more details based on the reviewers' comments. In summary, PC to eCN ratio was obtained by dividing the extrapolated number of PCs in the ASec and the CSec of the half vermis (average PC number in the ASec and CSec of a midline section multiplied by half the number of 14 μm-thick sections in half a CB) divided by the number of medial eCN present on every second section of half a CB using our two different methods (semi-automated eCN counting of cell type specific En1/2 CKOs and eCN-DTA mutants or stereology for *Atoh1-En1/2* cKOs).

> 5\) The reviewers also call for more contextual information about the potential role of neurotrophins, especially citation of classical literature on neurotrophins.

We had toned down our discussion of the neurotrophic theory in response to the previous comments that we do not have direct evidence for a particular neurotrophin, and at the same time we added the classical papers requested in our resubmission (Levi-Montalcini and Hamburger, 1951; Cowan et al., 1984). We have now added back an introduction to the neurotrophic theory in the Introduction and mention it in the Discussion section.

> Reviewer \#1:
>
> The manuscript has been extensively revised since its last submission with the addition of new data. These have addressed comments arising from the previous submission and the work provides convincing support for the hypothesis that the cerebellum size scales to the early assembled cerebellar nuclei.
>
> Reviewer \#2:
>
> \[...\] However, there are a number of questions associated with this study that are not addressed, and could at least be raised in the Discussion section.
>
> 1\) They mention (subsection "En1/2 are required in the eCN but not GCPs for growth of the cerebellar cortex") that En1/2 are necessary in the eCN compartment to promote cerebellar growth, but \"growth\" can reflect many different processes. Is this only due to apoptosis of neurons generated? Is there an effect on progenitor proliferation?

We have edited the sentences as follows:

"Taken together, our data demonstrate that En1/2 are necessary in the eCN compartment of the rhombic liplineage to promote postnatal growth of the cerebellar cortex. The numbers of interneurons and granule cells in the cerebellar cortex are scaled proportionately to the number of PCs, likely through decreased SHHstimulated proliferation of progenitors in *eCN-En1/2* CKOs as in *Atoh1-En1/2* CKO."

> 2\) They demonstrate that PCs are generated in normal numbers and there is increased cell death, suggesting that they lack trophic support from their target eCN neurons, although the PCs did not scale down completely. However, why there are fewer eCN neurons in the eCN-En1/2 cKO is not addressed, what is the mechanism by which the loss of En1/2 leads to the death of these eCN neurons?

Determining the mechanism for the death of the eCN in *eCN-En1/2* CKOs (and *eCN+GCP-En1/2* CKOs) is beyond the scope of the paper. In Figure 7 and Figure 7---figure supplement 2 we show that eCN are born in normal numbers and then die. The reason they are born normally could be because EN1/2 protein is not lost in the mutants until after they are born. Why EN1/2 are required for survival of only a subset of eCN could be because they are only expressed in a subset of eCN after E14 and/or because they have different functions in different eCN.

> 3\) There is no explanation or hypothesis provided in the Discussion for the regional differences in cerebellar growth in the Atoh1-En1/2 CKO, that the decreased size is only seen in the vermis and paravermis and not in the hemispheres, and only in the anterior and central, but not posterior sector. Is En1/2 equally expressed in all these regions? Does the Atoh1-Cre remove En1/2 from those regions that don\'t show decreased size after they have already developed?

We are sorry that we had not explained this clearly enough in the text. We had tried to explain that the reason for the decrease in size only in the vermis and paravermis and not in the hemispheres is because the eCN are only reduced in the medial and intermediate CN and these are the CN that the Purkinje cells in the vermis and paravermis project -- the hemispheres project to the lateral CN. In terms of the anterior and central sectors, but not posterior sector, as we had stated the posterior sector Purkinje cells do not project to the CB but instead to the vestibular nucleus (Results section). We have tried to modify our explanations.

> 4\) There was no scaling of the PV-positive inhibitory interneurons (figure 5), possible reasons for that could be discussed.

This is not correct. We show that the density of PV+ neurons is normal and the ML is decreased, thus the number of PV+ neurons is decreased in *eCN-En1/2* and *eCN+GCP-En1/2* CKOs.

> Reviewer \#3:
>
> \[...\] To this reviewer, however, the author\'s statement at the beginning of the discussion somehow appears to go beyond these conclusions: \'.. whereby the earliest-born neurons, the eCN, determine the cell number of their pre-synaptic partner PCs\'. According to what the authors write in the rebuttal \'our paper is addressing a.. scaling mechanism, which might be most prevalent after injury or used normally for making minor adjustments\'. Here the authors appear to recognize that additional mechanisms should be in place to match eCN and PCs, likely acting during neurogenesis. Therefore, the above reported statement sounds too strong and should be tuned down to better fit the results of this study.

We have revised the beginning of the Discussion section as follows:

In summary, the results of our studies show that development of the cerebellum involves a sequence of events that includes the earliest-born neurons, the eCN, having an influence on the final number of their pre-synaptic partner PCs by supporting their survival after PC neurogenesis is complete. In turn, the PCderived mitogenic factor, SHH, stimulates the proportional proliferation of GC, interneuron and glial progenitors and thus the level of production of all postnatally derived neurons in the cerebellar cortex (Figure 9).

> This reviewer is also confused now about how the ratio of PC to eCN in the medial nucleus is calculated. When reading the methods, it seems that the average number of PCs at the vermis midline (e.g. about 350+190 in WT mice, Figure 1L) is divided by the number of neurons in the medial nucleus (about 1000 in corresponding WT mice, Figure 1Q). The result here cannot be 20 as plotted in Figure 1---figure supplement 1M. Have I missed some information? Please, clarify.

We apologize for the confusion. As stated above in more detail, the number of PCs used for this calculation is an estimate of the total number of PC in the ASec and CSec of a half vermis not the number of PCs in the ASec + CSec of one midline section. We understand that this is a crude estimate, but it was used for purposes of comparing controls to mutants. We have revised the Materials and methods section to explain our calculation in more detail.

\[Editors\' note: the author responses to the re-review follow.\]

> We are pleased to inform you that the reviewers were satisfied with your revisions, most of which made your arguments better organized and the text clearer. Reviewer 1, however, had a few additional suggestions for further clarifying your writing, as follows:
>
> Introduction
>
> \"In turn, the PC-derived mitogenic factor, SHH, stimulates the proportional proliferation of GC, interneuron and glial progenitors and thus the level of production of all postnatally derived neurons in the cerebellar cortex (Figure 9)\"
>
> The suggested change is: rather than \"in turn\", it would be better to say \"Previous research indicates that\". This avoids any implication that these insights on Shh arise from this study. In addition, in many places, you cite the influence of Shh without making reference to the previous studies and so this also needs to be amended. Also, Shh is sometimes expressed as SHH -- make consistent.

As requested, we have replaced \"In turn," with \"Previous research indicates that\". We certainly were not trying to imply we discovered the role of SHH in stimulating GCPs and NEPs in this paper, and hence we had added the appropriate references at the end of the sentence (some of which are from our previous work).

I would like to make several comments.

First, this sentence is in the Discussion section not the Introduction.

Second, we had the following references in this sentence, after "(Figure 9)"

"(Corrales et al., 2006; Corrales et al., 2004; De Luca et al., 2015; Fleming et al., 2013; Lewis et al., 2004; Parmigiani et al., 2015; Wojcinski et al., 2017)"

Third, we have added the following references every place we mentioned SHH and had not included any references.

(Corrales et al., 2006; De Luca et al., 2015; Fleming et al., 2013; Lewis et al., 2004; Wojcinski et al., 2017).

Fourth, we are following the accepted nomenclature for mouse genes and proteins. http://www.informatics.jax.org/mgihome/nomen/. We use italics and lower case for genes and RNA (*Shh*) and all capitals for proteins (SHH). We have therefore not changed the nomenclature.

> Discussion section: \"...as it might not be able to support all the long range neural circuits needed for full motor function.\"
>
> This hypothesis needs a little elaboration. Is there any evidence from other studies that a small cerebellum, per se, results in motor deficits (i.e., in Shh mutants)?

In the subsection "*Atoh1-En1/2* mutants have motor deficits" we had previously included the following sentence first sentence "We next tested whether a smaller cerebellum that has a well scaled cortex can support normal motor behavior, since we had found that irradiated mice with an \~20% reduction in the area of mid-sagittal sections but well scaled layers have no obvious motor defects (Wojcinski et al., 2017)." We are not aware of any other paper that has analyzed behavior in mutants with a normal cyotoarchitecture but a smaller cerebellum. In *Shh* and *Gli* conditional mutants the granule cells and interneurons are not scaled to the number of Purkinje cells, as the Purkinje cells remain as a multilayer and the IGL is greatly diminished.

Based on observations of mice in their cages, we think the mutants have motor defects.

We have added that our mutants have an \~30% reduction in cerebellar size "smaller size of the cerebellum (\~30% reduction)" and added the following sentence to the Discussion section:

"In a previous study an \~20% reduction in the cerebellum without disruption of the cytoarchitecture did not lead to obvious motor defects, however the eCN and other cell types were not quantified and the reduction in size was less (Wojcinski et al., 2017)."

> Discussion section: \"One idea for the higher ratios of vermal PCs in lobules 1-8 \[...\] sufficient survival factor.\"
>
> These two sentences are rather tortuous and difficult to extract the argument. Please consider clarifying. Reviewer 1 tried to re-write the paragraph in a way that was clearer, in this way:
>
> \"The higher than expected ratio \[...\] less affected by the mutation.\"

We have replaced the difficult two sentences with the:

"The higher than expected ratio of PCs in the vermis to the medial eCN might reflect the way in which scaling is established. GC and interneuron numbers depend on a precise and deterministic proliferative response to SHH downstream of PC number (Corrales et al., 2006; De Luca et al., 2015; Fleming et al., 2013; Lewis et al., 2004; Wojcinski et al., 2017). In contrast, we propose that PC number depends on stochastic retrograde survival factors from the eCN. Moreover, PC survival could be complicated by the convergence ratio of \~40 PCs to each eCN (Person and Raman, 2011)."
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